Processing 00000000.tx.1: The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI Duong P. 

Phrase: "The autosomal recessive juvenile Parkinson disease gene product,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0017361:Recessive gene [Gene or Genome]
   818   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017337:Gene [Gene or Genome]
   795   C1514468:product [Entity]
   795   C1704444:Product [Quantitative Concept]
   790   C1416989:MAL gene [Gene or Genome]
   747   C1868675:Autosomal Recessive Juvenile Parkinson Disease [Disease or Syndrome]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with"

Phrase: "and"

Phrase: "ubiquitinates"

Phrase: "synaptotagmin XI Duong P."
Processing 00000000.tx.2: Huynh1,2, Daniel R. 

Phrase: "Huynh1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Daniel R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Scoles1,2, Dung Nguyen1 and Stefan M. 

Phrase: "Scoles1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Dung Nguyen1"

Phrase: "and"

Phrase: "Stefan M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Pulst1,2,3,* 1Rose Moss Laboratory for Neurogenetics, Parkinson's and Related Diseases, Burns and Allen Research Institute, Los Angeles, CA, USA, 2Division of Neurology, 8700 Beverly Blvd, Davis 2094E, Cedars-Sinai Medical Center, Los Angeles, CA, USA and 3Department of Neurobiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA Received May 14, 2003; 

Phrase: "Pulst1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "* 1Rose Moss Laboratory for Neurogenetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "Parkinson's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Related Diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006434:Burns [Injury or Poisoning]
   966 E C1550619:Burn [Substance]

Phrase: "and"

Phrase: "Allen Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "2Division of Neurology,"

Phrase: "8700 Beverly Blvd,"

Phrase: "Davis 2094E,"

Phrase: "Cedars-Sinai Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "3Department of Neurobiology,"

Phrase: "David Geffen School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "at UCLA,"

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA 90048,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 14,"

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.5: Accepted August 1, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Inactivating mutations of the gene encoding parkin are responsible for some forms of autosomal recessive juvenile Parkinson disease. 

Phrase: "Accepted August 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inactivating mutations of the gene encoding parkin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "responsible for some"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "forms of autosomal recessive juvenile Parkinson disease."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   897   C1868675:Autosomal Recessive Juvenile Parkinson Disease [Disease or Syndrome]
   814   C0752105:Parkinson Disease, Juvenile [Disease or Syndrome]
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   774   C0277561:Juvenile disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0596142:autosomal [Cell Component]
   748   C1522492:Form [Functional Concept]
   748   C3146221:Juvenile [Age Group]
Processing 00000000.tx.6: Parkin is a ubiquitin ligase that ubiquitinates misfolded proteins targeted for the proteasome-dependent protein degradation pathway. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin ligase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "ubiquitinates"

Phrase: "misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "targeted for the proteasome-dependent protein degradation pathway."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   770   C0597297:Protein Degradation [Molecular Function]
   770   C0597304:Protein Degradation [Molecular Function]
   770   C1511758:Degradation Pathway [Conceptual Entity]
   770   C1623036:Protein Degradation [Molecular Function]
   767   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   750   C1159372:protein target [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1325620:proteasome [Cell Component]
   744   C1521840:Targeted [Functional Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C3244310:dependent [Functional Concept]
   731 E C1523807:proteasomal pathway [Molecular Function]
   711 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.7: Using the yeast two-hybrid system and co-immunoprecipitation methods, we identified synaptotagmin XI as a protein that interacts with parkin. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid system"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "co-immunoprecipitation methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "synaptotagmin XI as a protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1426106:synaptotagmin XI [Gene or Genome]
   760   C1720296:Xi [Intellectual Product]

Phrase: "that"

Phrase: "interacts with parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.8: Parkin binds to the C2A and C2B domains of synaptotagmin XI resulting in the polyubiquitination of synaptotagmin XI. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "binds to the C2A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "C2B domains of synaptotagmin XI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "resulting in the polyubiquitination of synaptotagmin XI."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0332294:Resulting in [Functional Concept]
   778   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1426106:synaptotagmin XI [Gene or Genome]
   748   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0678226:resulting [Functional Concept]
   748   C1514216:Polyubiquitination [Molecular Function]
   748   C1720296:Xi [Intellectual Product]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]
Processing 00000000.tx.9: Truncated and missense mutated parkins reduce parkin-sytXI binding affinity and ubiquitination. 

Phrase: "Truncated"

Phrase: "and"

Phrase: "missense mutated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1418270:PARKIN [Gene or Genome]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reduce"

Phrase: "parkin-sytXI binding affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "ubiquitination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.10: Parkin-mediated ubiquitination also enhances the turnover of sytXI. 

Phrase: "Parkin-mediated ubiquitination also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519751:Ubiquitination [Molecular Function]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the turnover of sytXI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.11: In sporadic PD brain sections, sytXI was found in the core of the Lewy bodies. 

Phrase: "In sporadic PD brain sections,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "sytXI"

Phrase: "was"

Phrase: "found in the core of the Lewy bodies."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   776   C3546702:Lewy body core [Cell Component]
   770   C0085200:Lewy Bodies [Cell Component]
   744   C0150312:Found [Quantitative Concept]
   744   C0242821:bodies [Human]
   744   C0444669:Core [Spatial Concept]
   744   C1167518:core [Cell Component]
   744   C1706352:Core [Medical Device]
   744   C1882467:Core [Manufactured Object]
   744   C1995017:Bodies [Cell Component]
   744   C3274653:Core [Body Substance]
   711 E C0243095:Find [Finding]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.12: Since synaptotagmin XI is a member of the synaptotagmin family that is well characterized in their importance for vesicle formation and docking, the interaction with this protein suggests a role for parkin in the regulation of the synaptic vesicle pool and in vesicle release. 

Phrase: "Since"

Phrase: "synaptotagmin XI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]

Phrase: "is"

Phrase: "a member of the synaptotagmin family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "is"

Phrase: "well characterized in their importance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C1880022:Characterized [Activity]
   760   C3146287:Well [Manufactured Object]

Phrase: "for vesicle formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1749557:vesicle formation [Cell Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "docking,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0442632:docking [Manufactured Object]
  1000   C1522290:Docking [Molecular Function]
   966 E C0330386:Dock [Plant]

Phrase: "the interaction with this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0872079:interaction protein [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of the synaptic vesicle pool"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337051:Pool [Geographic Area]
   827   C1509144:pool [Clinical Attribute]
   827   C2349200:Pool [Functional Concept]
   734   C0039065:Synaptic vesicle [Cell Component]

Phrase: "and in vesicle release."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0030685:Release [Health Care Activity]
   770   C0333262:Vesicle [Acquired Abnormality]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1622418:vesicle [Cell Component]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.13: Loss of parkin could thus affect multiple proteins controlling vesicle pools, docking and release and explain the deficits in dopaminergic function seen in patients with parkin mutations.  

Phrase: "Loss of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "could"

Phrase: "thus"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "multiple proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "vesicle pools,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0337051:pools [Geographic Area]
   827 E C1509144:pool [Clinical Attribute]
   827 E C2349200:Pool [Functional Concept]

Phrase: "docking"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0442632:docking [Manufactured Object]
  1000   C1522290:Docking [Molecular Function]
   966 E C0330386:Dock [Plant]

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "explain"

Phrase: "the deficits in dopaminergic function"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "seen in patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "with parkin mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a major neurodegenerative disease characterized by muscle rigidity, tremor and bradykinesia (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a major neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "characterized by muscle rigidity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0026837:Muscle Rigidity [Sign or Symptom]
           Rigidity, NOS
   770   C0026845:Muscle [Tissue]
   770   C0700109:rigidity [Natural Phenomenon or Process]
   770   C1880022:Characterized [Activity]

Phrase: "tremor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040822:Tremor [Sign or Symptom]
  1000   C1963252:Tremor [Finding]

Phrase: "and"

Phrase: "bradykinesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Other symptoms such as postural deficits, gait impairment and dementia are also observed in a subpopulation of PD patients. 

Phrase: "Other symptoms such as postural deficits,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3257980:Other symptoms [Sign or Symptom]
   753   C0683368:symptoms [Functional Concept]
   753   C1457887:Symptoms [Sign or Symptom]

Phrase: "gait impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "are"

Phrase: "also"

Phrase: "observed in a subpopulation of PD patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C1257890:Subpopulation [Population Group]
   748   C1441672:Observed [Functional Concept]
Processing 00000000.tx.16: Although the majority of idiopathic PD cases are sporadic and probably influenced by environmental factors, familial aggregation of cases and rare Mendelian inheritance of PD traits evince the importance of genetic factors. 

Phrase: "Although"

Phrase: "the majority of idiopathic PD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "influenced by environmental factors,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1516998:Environmental Factors [Functional Concept]
   816 E C0686732:Environmental Factor [Qualitative Concept]
   802   C0814287:factors influence [Clinical Attribute]
   770   C0014406:Environmental [Spatial Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "familial aggregation of cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "rare Mendelian inheritance of PD traits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0683231:Mendelian inheritance [Genetic Function]
   753   C0242538:Inheritance [Quantitative Concept]
   753   C0728826:Inheritance [Functional Concept]

Phrase: "evince"

Phrase: "the importance of genetic factors."
Processing 00000000.tx.17: In PD, the level of dopamine is decreased in the striatum, most severely in the putamen. 

Phrase: "In PD,"

Phrase: "the level of dopamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "decreased in the striatum,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0010097:Striatum [Body Part, Organ, or Organ Component]
   770   C0162512:Striatum [Body Part, Organ, or Organ Component]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "most severely in the putamen."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034169:Putamen [Body Part, Organ, or Organ Component]
   760   C0205082:Severely [Qualitative Concept]
   760   C0205393:Most [Quantitative Concept]
   760   C1281335:Putamen [Body Part, Organ, or Organ Component]
Processing 00000000.tx.18: This is largely a result of degeneration of dopamine-producing neurons in the substantia nigra pars compacta (24). 

Phrase: "This"

Phrase: "is"

Phrase: "largely"

Phrase: "a result of degeneration of dopamine-producing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "in the substantia nigra pars compacta"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.19: To date, the three genes that have been associated with autosomal dominant PD are NR4A2 (5), -synuclein (6), and ubiquitin C-terminal hydroxylase L1 (UCHL1) (7). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "the three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "associated with autosomal dominant PD"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0596142:autosomal [Cell Component]
   760   C1527180:Dominant [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "NR4A2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417836:NR4A2 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ", -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ubiquitin C-terminal hydroxylase L1 (UCHL1) (7"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   827   C0949722:Ubiquitin C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1421267:UBIQUITIN C [Gene or Genome]
   827   C1523983:Ubiquitin C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0205088:Terminal [Temporal Concept]
   799   C0441918:L1 [Finding]
   799   C1179698:L1 [Body Location or Region]
   799   C1416177:L1 [Gene or Genome]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.20: The two genes that have been associated with autosomal recessive PD are parkin (8) and DJ-1 (9). 

Phrase: "The two genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "associated with autosomal recessive PD"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441748:Autosomal recessive [Intellectual Product]
   760   C0596142:autosomal [Cell Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(8"

Phrase: ")"

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.21: Inactivating mutations of the parkin gene cause PARK2 autosomal recessive juvenile Parkinsonism (AR-JP). 

Phrase: "Inactivating mutations of the parkin gene cause PARK2 autosomal recessive juvenile Parkinsonism (AR-JP)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   751   C0596611:gene mutations [Genetic Function]
   736   C0026882:Mutations [Genetic Function]
   703 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.22: Similar to other PD forms, PARK2 is characterized by loss of dopaminergic neurons in the substantia nigra. 

Phrase: "Similar to other PD forms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "PARK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARK2 [Gene or Genome]
  1000   C1868675:PARK2 [Disease or Syndrome]

Phrase: "is"

Phrase: "characterized by loss of dopaminergic neurons"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C3550005:Loss of dopaminergic neurons [Finding]
   820   C0598940:Loss of neurons [Finding]
           neuron loss
   790   C1512035:Dopaminergic Neurons [Cell]
   753   C0027882:Neurons [Cell]
   753   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C1517945:Loss [Quantitative Concept]
   753   C1880022:Characterized [Activity]
   742 E C1850496:Neuronal loss [Finding]

Phrase: "in the substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.23: However, PARK2 is unique in that Lewy bodies in substantia nigra neurons are absent in most cases of AR-JP (1012). 

Phrase: "However,"

Phrase: "PARK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARK2 [Gene or Genome]
  1000   C1868675:PARK2 [Disease or Syndrome]

Phrase: "is"

Phrase: "unique in that Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710548:Unique [Qualitative Concept]

Phrase: "in substantia nigra neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   734   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "absent in most cases of AR-JP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:Absent [Quantitative Concept]
   742   C2699517:ABSENT [Finding]

Phrase: "(1012"

Phrase: ")."
Processing 00000000.tx.24: Mutations in the parkin gene cause a form of AR-JP, but are also found in older PD patients demonstrating that parkin mutations are not limited to juvenile onset (13). 

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a form of AR-JP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "are"

Phrase: "also"

Phrase: "found in older PD patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
   726   C0580836:Old [Temporal Concept]

Phrase: "demonstrating"

Phrase: "that parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "limited to juvenile onset"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C3149653:Juvenile onset [Finding]
   770   C0332162:Onset [Qualitative Concept]
   770   C0439801:Limited [Functional Concept]
   770   C3146221:Juvenile [Age Group]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.25: Parkin is composed of a ubiquitin-like domain in the N-terminal domain and two RING finger motifs toward the C-terminus (8,14). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "composed of a ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "in the N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "two RING finger motifs toward the C-terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1521759:RING Finger Motifs [Cell Component]
   711   C1514562:Motif [Amino Acid Sequence]

Phrase: "(8,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: Several inactivating mutations are found in the RING finger domains and suggest that these domains are functionally important (15). 

Phrase: "Several inactivating mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "found in the RING finger domains"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C1521759:RING Finger Domains [Cell Component]
           Ring Finger
   790   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   753   C0016129:Finger [Body Location or Region]
   753   C0150312:Found [Quantitative Concept]
   753   C0521164:Ring [Spatial Concept]
   753   C1260969:Ring [Medical Device]
   753   C1281584:Finger [Body Part, Organ, or Organ Component]
   753   C1705184:Ring [Medical Device]
   719 E C0243095:Find [Finding]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "functionally important"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.27: To date, only one missense (Arg42Pro) and three frameshift mutations have been found in the ubiquitin-like domain. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "only one missense"

Phrase: "(Arg42Pro"

Phrase: ")"

Phrase: "and"

Phrase: "three frameshift mutations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0079380:Mutations, Frame Shift [Cell or Molecular Dysfunction]
           Frameshift
   884 E C1282684:Frame-shift mutation [Laboratory or Test Result]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "found in the ubiquitin-like domain."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0150312:Found [Quantitative Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.28: Shimura et al. 

Phrase: "Shimura et al."
Processing 00000000.tx.29: (14) demonstrated that the ubiquitin-conjugating H7 protein binds to the RING finger domain, and that the RING domains of parkin are required for ubiquitination in human dopaminergic SH-SY5Y neuroblastoma cells. 

Phrase: "(14"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the ubiquitin-conjugating H7 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to the RING finger domain,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1521759:Ring Finger Domain [Cell Component]
           Ring Finger
   790   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   753   C0016129:Finger [Body Location or Region]
   753   C0521164:Ring [Spatial Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1260969:Ring [Medical Device]
   753   C1281584:Finger [Body Part, Organ, or Organ Component]
   753   C1705184:Ring [Medical Device]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "the RING domains of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "required for ubiquitination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514873:Required [Functional Concept]
   790   C1519751:Ubiquitination [Molecular Function]

Phrase: "in human dopaminergic SH-SY5Y neuroblastoma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   895   C0427861:Human cells [Laboratory or Test Result]
   876   C1512035:Dopaminergic cells [Cell]
   810   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.30: These observations suggest different roles for the ubiquitin-like and RING finger domains. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "different roles for the ubiquitin-like"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "RING finger domains."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1521759:RING Finger Domains [Cell Component]
           Ring Finger
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
   734   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
Processing 00000000.tx.31: Subsequently, the ubiquitin-like domain was found to be important for the stability of parkin (16) and probably for targeting the ubiquitinated substrates to the proteasome. 

Phrase: "Subsequently,"

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important for the stability of parkin"

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "probably for targeting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0750492:Probably [Idea or Concept]
   790   C1521840:Targeting [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the ubiquitinated substrates to the proteasome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.32: The RING fingers, on the other hand, bind to substrates and other ubiquitin components, such as UbcH7 (E2), required for the ubiquitin-ligase activity. 

Phrase: "The RING fingers,"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   966   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   966   C1521759:Ring Finger [Cell Component]
   861   C0016129:Fingers [Body Location or Region]
   861   C0521164:Ring [Spatial Concept]
   861   C0549188:fingers [Quantitative Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]
   827 E C1281584:Finger [Body Part, Organ, or Organ Component]
   789 E C0442015:Digital [Intellectual Product]
   789 E C1883674:Digital [Qualitative Concept]
   761 E C0582802:Digit [Body Part, Organ, or Organ Component]
   761 E C1283912:Digit [Body Part, Organ, or Organ Component]
   761 E C3241971:Digit [Quantitative Concept]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "bind to substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   756   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "other ubiquitin components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "such as UbcH7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421286:UBCH7 [Gene or Genome]

Phrase: "(E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "required for the ubiquitin-ligase activity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1150685:ubiquitin-ligase activity [Molecular Function]
   790   C1150651:ligase activity [Molecular Function]
   783   C1325411:ubiquitin activity [Molecular Function]
   753   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1514873:Required [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.33: Zhang et al. 

Phrase: "Zhang et al."
Processing 00000000.tx.34: (17) confirmed this observation and further found that parkin bound to CDCrel-1, a member of a synaptic vesicle-associated protein family named septin, and that parkin stimulated the ubiquitination and turnover of this protein. 

Phrase: "(17"

Phrase: ")"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "this observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "bound to CDCrel-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   833   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1539748:CDCREL [Gene or Genome]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "a member of a synaptic vesicle-associated protein family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "septin,"

Phrase: "and"

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "turnover of this protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0597297:Protein Turnover [Molecular Function]
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.35: Together, these data led to the suggestion that parkin functions as an E3 ubiquitin ligase. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "led to the suggestion"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0038659:Suggestion [Idea or Concept]
   770   C1705535:suggestion [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that parkin functions as an E3 ubiquitin ligase."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.36: The E3 ubiquitin ligases together with the activating E1 and often with the conjugating E2 enzymes catalyze the conjugation of ubiquitin chains to cytoplasmic proteins targeted for degradation in the 26S proteasome complex, thus regulating important cellular processes such as cell cycle, cell death and cell differentiation. 

Phrase: "The E3 ubiquitin ligases together with the activating E1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   779   C1418270:E3 ubiquitin ligase [Gene or Genome]
   742   C0023689:Ligases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "often with the conjugating E2 enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C0332183:Often [Temporal Concept]
   753   C3539520:E2 [Gene or Genome]
   719   C0301869:Conjugate [Immunologic Factor]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the conjugation of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "chains to cytoplasmic proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0010834:Cytoplasmic [Cell Component]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0337112:Chain [Manufactured Object]
   770   C0521449:Cytoplasmic [Body Location or Region]
   770   C1524075:Chain [Idea or Concept]

Phrase: "targeted for degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the 26S proteasome complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1166804:26S proteasome [Cell Component]

Phrase: "thus"

Phrase: "regulating"

Phrase: "important cellular processes such as cell cycle,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   788   C1155839:Cell Cycle Process [Cell Function]
   788   C1818617:cell cycle process [Cell Function]
   774   C0230625:cell processes [Cell Component]
   762   C0007613:Cellular Process [Cell Function]
       E   Cell Process
   762   C1325880:cellular process [Cell Function]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.37: The ubiquitinated substrate can be degradated either through the proteasome-dependent pathway (18) if the substrate is polyubiquitinated, or through the lysosomal degradation pathway if the protein is monoubiquitinated. 

Phrase: "The ubiquitinated substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "degradated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243125:Degradated [Functional Concept]

Phrase: "either through the proteasome-dependent pathway"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C3244310:dependent [Functional Concept]
   748 E C1523807:proteasomal pathway [Molecular Function]

Phrase: "(18"

Phrase: ")"

Phrase: "if"

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "is"

Phrase: "polyubiquitinated"

Phrase: ","

Phrase: "or through the lysosomal degradation pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1511758:Degradation Pathway [Conceptual Entity]
   753   C0243125:degradation [Functional Concept]
   753   C0521450:Lysosomal [Body Location or Region]
   753   C0699900:Degradation [Organism Function]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "if"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "monoubiquitinated."
Processing 00000000.tx.38: Monoubiquitination can cause certain cell surface receptors (e.g. EGF receptor) to internalize or can function as a protein sorting signal in the endosomal pathway (1921), and direct these monoubiquitinated proteins to the lysosome. 

Phrase: "Monoubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513486:Monoubiquitination [Molecular Function]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "certain cell surface receptors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   861   C0699040:Cell surface [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0205148:Surface [Spatial Concept]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "e.g. EGF receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "internalize"

Phrase: "or"

Phrase: "can"

Phrase: "function as a protein sorting signal"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0887827:Sorting Signal, Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0887837:Protein Sorting [Cell Function]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0237886:Sorting [Mental Process]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C0700314:sorting [Cell Function]
   753   C1705273:Function [Intellectual Product]
   753   C1710082:Signal [Phenomenon or Process]
   753   C1947906:Sorting [Activity]

Phrase: "in the endosomal pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(1921"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "these monoubiquitinated proteins to the lysosome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0065400:lysosomal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1327384:protein monoubiquitination [Molecular Function]
Processing 00000000.tx.39: Parkin has been found to interact with several proteins which include the Pael-R receptor (22), CDCrel-1 (17), glycosylated -synuclein (23), synphilin-1 (24), CHIP (25), cyclin E (26), HSP70 (27), /-tubulin (28), and the p38 subunit of the aminoacyl t-RNA synthetase complex (29). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the Pael-R receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "glycosylated -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "CHIP (25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600596:Chip [Research Device]

Phrase: ")"

Phrase: ","

Phrase: "cyclin E (26"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332697:CYCLIN E [Gene or Genome]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "HSP70 (27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1415760:HSP70 [Gene or Genome]
   861   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "/-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the p38 subunit of the aminoacyl t-RNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.40: Parkin-mediated ubiquitination led to the degradation of these proteins by the proteasome system. 

Phrase: "Parkin-mediated ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519751:Ubiquitination [Molecular Function]

Phrase: "led to the degradation of these proteins"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   757   C0597297:Protein Degradation [Molecular Function]
   757   C0597304:Protein Degradation [Molecular Function]
   757   C1623036:Protein Degradation [Molecular Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by the proteasome system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.41: Absence of parkin-mediated degradation of the Pael-R receptor resulted in the accumulation of the Pael-R receptor causing cell death (22). 

Phrase: "Absence of parkin-mediated degradation of the Pael-R receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332197:absence [Quantitative Concept]
   739   C1689985:Absence [Anatomical Abnormality]

Phrase: "resulted in the accumulation of the Pael-R receptor causing cell death"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   755   C0007465:Cause of Death [Finding]
           Death Cause
   755   C0804771:Cause of death [Clinical Attribute]
   753   C0007587:Cell Death [Cell Function]
   751   C1514760:Receptor Cell [Cell]
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C0205090:R- [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0678227:Causing [Functional Concept]
   736   C0684010:R. [Professional or Occupational Group]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]
   736   C2603358:R' [Clinical Attribute]
   703 E C0015127:cause [Functional Concept]
   703   C1274040:Result [Functional Concept]
   703 E C1524003:Cause [Conceptual Entity]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.42: Using the yeast two-hybrid screens, we found that parkin interacted with synaptotagmin XI, and this interaction resulted in its ubiquitination and degradation. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid screens,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   779   C0220908:screen [Health Care Activity]
   779   C1305399:screen [Functional Concept]
   779   C1705053:Screen [Medical Device]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacted with synaptotagmin XI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1426106:synaptotagmin XI [Gene or Genome]
   770   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1720296:Xi [Intellectual Product]

Phrase: "and"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "resulted in its ubiquitination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1519751:Ubiquitination [Molecular Function]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.43: The interaction with a member of the synaptotagmin family suggests an involvement of parkin in the regulation of proteins involved in controlling neurotransmitter trafficking at the presynaptic terminal.  

Phrase: "The interaction with a member of the synaptotagmin family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an involvement of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in controlling neurotransmitter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]
   770   C0332298:controlling [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C2587213:Controlling [Functional Concept]

Phrase: "trafficking at the presynaptic terminal."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0206181:Presynaptic Terminal [Cell Component]
   760   C0205088:Terminal [Temporal Concept]
   760   C0599896:trafficking [Cell Function]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.44: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Identification of parkin interactors by the yeast two-hybrid system Using the yeast two-hybrid method (30), we screened a human fetal brain pGAD10-cDNA library using the pGBT9-parkin (1465) construct. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of parkin interactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "by the yeast two-hybrid system"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid method"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0752172:Two-Hybrid Method [Molecular Biology Research Technique]
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0025663:Method [Intellectual Product]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449851:Method [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "a human fetal brain pGAD10-cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   799   C0023621:Library [Manufactured Object,Organization]
   799   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the pGBT9-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1465"

Phrase: ")"

Phrase: "construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]
Processing 00000000.tx.45: Six potential clones were identified in 2x106 independent human fetal brain pGAD10-cDNA colonies. 

Phrase: "Six potential clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "identified in 2x106 independent human fetal brain pGAD10-cDNA colonies."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   760   C0440731:Fetal brain [Embryonic Structure]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0015965:Fetal [Embryonic Structure]
   739   C0085862:Independent [Idea or Concept]
   739   C0086418:Human [Human]
   739   C0205396:Identified [Qualitative Concept]
   739   C0439158:colonies [Quantitative Concept]
   739   C0521457:Fetal [Functional Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1299583:Independent [Finding]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   706 E C1947989:Colony [Cell]
Processing 00000000.tx.46: These clones were individually isolated, sequenced and subjected to further yeast two-hybrid filter assays to confirm the interactions. 

Phrase: "These clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "individually"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ","

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "subjected to further yeast two-hybrid filter assays to"
Meta Candidates (Total=25; Excluded=1; Pruned=0; Remaining=24)
   810   C1961118:Yeast Two-Hybrid Assays [Molecular Biology Research Technique]
   784   C0752172:Two-Hybrid Assays [Molecular Biology Research Technique]
   764   C0599647:Two Hybrid [Molecular Biology Research Technique]
   742   C0020205:Hybrid [Organism]
   742   C0036025:yeast [Fungus]
   742   C0043392:Yeast [Food]
   742   C0043393:Yeast [Fungus]
   742   C0180860:Filter [Manufactured Object]
   742   C0205448:Two [Quantitative Concept]
   742   C0581406:Filter [Medical Device]
   742   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   742   C1517331:Further [Spatial Concept]
   742   C1522664:Filter [Intellectual Product]
   742   C1704449:Filter [Conceptual Entity]
   742   C1704684:Filter [Medical Device]
   742   C1875155:FILTER [Medical Device]
   708   C0005507:Assay [Laboratory Procedure]
   708 E C0205108:far [Spatial Concept]
   708   C0243073:assay [Qualitative Concept]
   708   C0681850:Subject [Group]
   708   C1510438:Assay [Laboratory Procedure]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.47: Two of these clones had a long open-reading frame and therefore were purified and sequenced. 

Phrase: "Two of these clones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "had"

Phrase: "a long open-reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.48: Nucleotide sequences showed that one of the two clones encoded the C2A and C2B domains of the human synaptotagmin XI, and this clone was designated hsytXIAB (for human synaptotagmin XI, domains C2A and C2B). 

Phrase: "Nucleotide sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0004793:Sequences, Nucleotide [Nucleotide Sequence]
       E   Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that one of the two clones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "the C2A"

Phrase: "and"

Phrase: "C2B domains of the human synaptotagmin XI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "this clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "hsytXIAB"

Phrase: "("

Phrase: "for human synaptotagmin XI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1426106:synaptotagmin XI [Gene or Genome]
   827   C1720296:Xi [Intellectual Product]

Phrase: "domains C2A"

Phrase: "and"

Phrase: "C2B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469680:C2B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.49: To further determine if the hsytXIAB fragment was a true parkin interactor, the purified pGAD10-hsytXIAB was co-transfected into Y190 yeast cells with either pGBT9-parkin (1465), or with two unrelated baits, pGBT9-NF2 (encoding the schwannomin tumor suppressor), and pGBT9-Hrs (Hrs=hepatocyte growth factor regulated kinase substrate) constructs (31) or the pGBT9 vector. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the hsytXIAB fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "a true parkin interactor,"

Phrase: "the purified pGAD10-hsytXIAB"

Phrase: "was"

Phrase: "co-transfected into Y190 yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C2700289:Yeast Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with either pGBT9-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1465"

Phrase: ")"

Phrase: ","

Phrase: "or with two unrelated baits,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]

Phrase: "pGBT9-NF2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0027832:Neurofibromatosis 2 [Neoplastic Process]
   827   C0027831:Neurofibromatosis [Neoplastic Process]
   827   C0085113:neurofibromatosis [Gene or Genome]
   827   C0162678:Neurofibromatosis [Neoplastic Process]
   827   C3540584:Neurofibromatosis [Intellectual Product]

Phrase: "("

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the schwannomin tumor suppressor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0079427:Tumor Suppressor [Gene or Genome]
   901   C1325410:tumor suppressor [Cell Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C1710252:Suppressor [Manufactured Object]
   827   C2954564:Suppressor [Pharmacologic Substance]
   827   C3273930:Tumor [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pGBT9-Hrs"

Phrase: "(Hrs"

Phrase: "=hepatocyte growth factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0227525:Hepatocyte [Cell]
   827   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "kinase substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "the pGBT9 vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.50: Filter binding assays demonstrated that only the pGAD10-hsytXIAB clone showed positive interaction with the pGBT9-parkin construct but not with the pGBT9 vector control or unrelated proteins (Fig.1A). 

Phrase: "Filter"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "binding assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the pGAD10-hsytXIAB clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positive interaction with the pGBT9-parkin construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "but"

Phrase: "not with the pGBT9 vector control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0031249:vector control [Occupational Activity]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1518422:Not [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "unrelated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.51: To confirm parkin interaction by yeast two-hybrid liquid assays, transfected yeast colonies were grown in liquid culture and tested for -galactosidase activity. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "parkin interaction by yeast two-hybrid liquid assays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "transfected yeast colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "grown in liquid culture"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0302908:Liquid [Substance]
   770   C0430400:Culture [Laboratory Procedure]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1561501:Liquid NOS [Substance]
   770   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "tested for -galactosidase activity."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1150051:galactosidase activity [Molecular Function]
   770   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0392366:tested [Intellectual Product]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
Processing 00000000.tx.52: Yeast cells co-transfected with pGAD10hsytXIAB and pGBT9parkin produced about 20-fold higher -galactosidase activity compared with yeast cells co-expressing pGAD10-hsytX1AB and pGBT9 vector control (Fig.1B). 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with pGAD10hsytXIAB"

Phrase: "and"

Phrase: "pGBT9parkin"

Phrase: "produced about 20-fold higher -galactosidase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1150051:galactosidase activity [Molecular Function]
   748   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0332462:Fold [Spatial Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "compared with yeast cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C2700289:Yeast Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "pGAD10-hsytX1AB"

Phrase: "and"

Phrase: "pGBT9 vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0031249:vector control [Occupational Activity]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243148:control [Qualitative Concept]
   827   C0442335:Vector [Spatial Concept]
   827   C1550141:Control [Substance]
   827   C1705099:Vector [Idea or Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: View larger version (37K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.54: Parkin interacts with the C2A and C2B domains of sytXI. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with the C2A"

Phrase: "and"

Phrase: "C2B domains of sytXI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.55: (A) Yeast two-hybrid filter assay. 

Phrase: "(A) Yeast two-hybrid filter assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   867   C0752172:Two-Hybrid Assay [Molecular Biology Research Technique]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.56: Yeast Y190 cells transformed with pGAD10hsytXIAB and pGBT9parkin produced a positive reaction with -gal substrate (blue color), while yeast cells transformed with pGAD10hsytXIAB and the pGBT9vector control did not. 

Phrase: "Yeast Y190 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C2700289:Yeast Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transformed with pGAD10hsytXIAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "pGBT9parkin"

Phrase: "produced"

Phrase: "a positive reaction with -gal substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "(blue color"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1260957:Blue color [Qualitative Concept]
   861   C0009393:Color [Natural Phenomenon or Process]
   861   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   861   C1705245:Color [Pharmacologic Substance]
   789 E C0522507:colored [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transformed with pGAD10hsytXIAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "the pGBT9vector control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.57: Yeast cells transformed with pGAD10hsytXIAB and two other controls expressing schwannomin and Hrs (pGBT9NF2, and pGBT9Hrs) failed to form positive reactions with the -gal substrate. 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transformed with pGAD10hsytXIAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "expressing"

Phrase: "schwannomin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085114:SCHWANNOMIN [Gene or Genome]
  1000   C0254123:Schwannomin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Hrs"

Phrase: "(pGBT9NF2,"

Phrase: "and"

Phrase: "pGBT9Hrs"

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "positive reactions with the -gal substrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0443286:Reaction [Functional Concept]
   719   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.58: These control proteins are functional in the yeast two-hybrid system as previously described in Scoles et al. 

Phrase: "These control proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "functional in the yeast two-hybrid system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1180473:Functional system [Body System]
   748   C0205245:Functional [Functional Concept]
   748   C0542341:Functional [Functional Concept]
   748   C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "previously"

Phrase: "described in Scoles et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.59: (31,37). 

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.60: (B) Yeast two-hybrid liquid assay. 

Phrase: "(B) Yeast two-hybrid liquid assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   867   C0752172:Two-Hybrid Assay [Molecular Biology Research Technique]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.61: Yeast cells transformed with pGAD10hsytXIAB and pGBT9parkin plasmids produced 20-fold more -gal activity than yeast cells transformed with pGAD10hsytAB (lane 1) and the pGAD10 vector control (lane 2). 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transformed with pGAD10hsytXIAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "pGBT9parkin plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "produced"

Phrase: "20-fold more -gal activity than yeast cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "transformed with pGAD10hsytAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the pGAD10 vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0031249:vector control [Occupational Activity]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243148:control [Qualitative Concept]
   827   C0442335:Vector [Spatial Concept]
   827   C1550141:Control [Substance]
   827   C1705099:Vector [Idea or Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.62: Each bar graph represents n=3.  

Phrase: "Each bar graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681493:Graph [Intellectual Product]
   861   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "n=3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.63: Specificity of antibodies to synaptotagmin I and XI We generated rabbit antibodies to two peptides of synaptotagmin XI (anti-sytXIA and anti-sytXIB) and purchased a mouse antibody to synaptotagmin 1 (anti-syt65). 

Phrase: "Specificity of antibodies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0003264:antibodies specificity [Molecular Function]
   805 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "to synaptotagmin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0144255:synaptotagmin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420556:synaptotagmin I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "XI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "We"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "rabbit antibodies to two peptides of synaptotagmin XI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-sytXIA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-sytXIB"

Phrase: ")"

Phrase: "and"

Phrase: "purchased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0869011:purchased [Activity]

Phrase: "a mouse antibody to synaptotagmin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-syt65"

Phrase: ")."
Processing 00000000.tx.64: Since sytI and sytXI are related proteins and have close homology to other synaptotagmins, we tested whether the anti-syt65 and anti-sytXI antibodies cross-reacted with each other before using these antibodies to investigate parkinsytXI interactions. 

Phrase: "Since"

Phrase: "sytI"

Phrase: "and"

Phrase: "sytXI"

Phrase: "are"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "have"

Phrase: "close homology to other synaptotagmins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the anti-syt65"

Phrase: "and"

Phrase: "anti-sytXI antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "cross-reacted with each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2828360:Cross [Conceptual Entity]

Phrase: "before"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "parkinsytXI interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.65: Figure 2A shows western blots of protein extracts isolated from human embryonic kidney (HEK) 293T cells expressing GFP- sytI, GFP-sytIV, GFP-sytXI or GFP. 

Phrase: "Figure 2A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "western blots of protein extracts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "isolated from human embryonic kidney (HEK) 293T cells"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   774   C0427861:Human cells [Laboratory or Test Result]
   774   C0553257:cells kidney [Cell]
   757   C1947950:Embryonic Cell [Embryonic Structure]
   748   C0007634:Cells [Cell]
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0205409:Isolated [Functional Concept]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]
   748   C1548221:Isolated [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C0370215:Isolate [Substance]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "GFP- sytI,"

Phrase: "GFP-sytIV,"

Phrase: "GFP-sytXI"

Phrase: "or"

Phrase: "GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.66: The western blots were separately detected with anti-GFP, anti-syt65 or anti-sytXIA antibodies. 

Phrase: "The western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "separately"

Phrase: "detected with anti-GFP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "anti-syt65"

Phrase: "or"

Phrase: "anti-sytXIA antibodies."
Processing 00000000.tx.67: As expected, the anti-syt65 and anti-sytXIA antibodies detected only the respective GFPsytI or GFPsytXI proteins, while the anti-GFP antibodies detected all GFP-tagged proteins. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the anti-syt65"

Phrase: "and"

Phrase: "anti-sytXIA antibodies"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the respective GFPsytI"

Phrase: "or"

Phrase: "GFPsytXI proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "while"

Phrase: "the anti-GFP antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "all GFP-tagged proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.68: Importantly, the anti-sytXIA antibody did not detect GFPsytIV, even though sytIV has the closest homology with sytXI. 

Phrase: "Importantly,"

Phrase: "the anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "GFPsytIV,"

Phrase: "even"

Phrase: "though"

Phrase: "sytIV"

Phrase: "has"

Phrase: "the closest homology with sytXI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.69: View larger version (37K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.70: Parkin interacts with synaptotagmin XI. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with synaptotagmin XI."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1426106:synaptotagmin XI [Gene or Genome]
   770   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.71: (A) Specificity of antibodies to synaptotagmins I and XI. 

Phrase: "(A) Specificity of antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0003264:antibodies specificity [Molecular Function]
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]
   767 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to synaptotagmins I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0144255:synaptotagmin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C1420556:synaptotagmin I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "XI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.72: Western blots of protein extracts from HEK293 cells transfected with GFP and GFP-sytI, IV and XI plasmids were detected with antibodies to GFP, sytI and sytXI. 

Phrase: "Western blots of protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1705493:Western [Spatial Concept]

Phrase: "extracts from HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C2936239:HEK293 Cells [Cell]
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "GFP-sytI,"

Phrase: "IV"

Phrase: "and"

Phrase: "XI plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "detected with antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "sytI"

Phrase: "and"

Phrase: "sytXI."
Processing 00000000.tx.73: Both the anti-sytI and anti-sytXI antibodies specifically detected their respective epitopes but not the GFP-sytIV fusion protein. 

Phrase: "Both"

Phrase: "the anti-sytI"

Phrase: "and"

Phrase: "anti-sytXI antibodies specifically"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "their respective epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the GFP-sytIV fusion protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0286878:SytIV Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.74: nt=non-transfected cells. 

Phrase: "nt=non-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.75: (B) Western blots of protein extract from PC12 cells detected with rabbit anti-sytXIA antibody. 

Phrase: "(B) Western blots of protein extract"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1705493:Western [Spatial Concept]

Phrase: "from PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "detected with rabbit anti-sytXIA antibody."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   762   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0034493:Rabbit [Mammal]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.76: Lane 1, incubation with 1g/ml of anti-sytXIA antibody; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "incubation with 1g/ml of anti-sytXIA antibody"

Phrase: ";"
Processing 00000000.tx.77: lane 2, incubation with anti-sytXIA antibody preincubated with sytXIA peptide; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "incubation with anti-sytXIA antibody"

Phrase: "preincubated with sytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.78: lane 3, incubation with anti-syXIA antibody preincubated with sytXIB peptide. 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "incubation with anti-syXIA antibody"

Phrase: "preincubated with sytXIB peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.79: The anti-sytXIA antibody detects a single band at 64kDa. 

Phrase: "The anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a single band at 64kDa."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
Processing 00000000.tx.80: This band was preabsorbed out with preincubation with the sytXIA peptide but not with sytXIB peptide. 

Phrase: "This band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "preabsorbed"

Phrase: "out with preincubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "with the sytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "not with sytXIB peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.81: (C) Parkin-sytXI in vitro immunoprecipitation. 

Phrase: "(C) Parkin-sytXI in vitro immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.82: Protein extracts from HEK293 cells overexpressing HA-parkin and the corresponding GFP fusion proteins were coimmunoprecipitated (co-ip) with a mouse anti-GFP antibody. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C2936239:HEK293 Cells [Cell]
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "HA-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the corresponding GFP fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "coimmunoprecipitated"

Phrase: "("

Phrase: "co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "with a mouse anti-GFP antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.83: The IP products were detected with rat anti-HA-peroxidase (top panel) and a rabbit anti-GFP antibody (bottom panel). 

Phrase: "The IP products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "detected with rat anti-HA-peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0442726:Detected [Finding]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "a rabbit anti-GFP antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.84: The sytXI proteins co-precipitated parkin, but the GFP tag did not. 

Phrase: "The sytXI proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "the GFP tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.85: (D) Co-immunoprecipitation of endogenous parkin and sytXIA. 

Phrase: "("

Phrase: "D)"

Phrase: "Co-immunoprecipitation of endogenous parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "sytXIA."
Processing 00000000.tx.86: Protein extracts from a human cerebral cortex were co-immunoprecipitated with rabbit anti-parkA antibody (lane 1), or rabbit IgG (lane 2) as a control. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from a human cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   753   C0086418:Human [Human]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]
   753   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "co-immunoprecipitated with rabbit anti-parkA antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "rabbit IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "as a control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.87: The precipitates were detected with anti-parkA (top panel) or anti-sytXIA antibody (bottom panel). 

Phrase: "The precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "detected with anti-parkA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.88: The anti-parkA antibody co-immunoprecipitated sytXI but the rabbit IgG control did not. 

Phrase: "The anti-parkA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "sytXI"

Phrase: "but"

Phrase: "the rabbit IgG control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.89: To do the reverse co-ip, protein extracts were co-ip with rabbit anti-sytXI antiserum (lane 3) or the corresponding preserum at identical dilutions (lane 4). 

Phrase: "To do"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "the reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "co-ip with rabbit anti-sytXI antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "the corresponding preserum at identical dilutions"

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.90: The western blot was detected with the chicken anti-parkA (lanes 3 and 4), which detected the endogenous parkin band in the anti-sytXI antiserum (lane 3), but not in the preserum control (lane 4).  

Phrase: "The western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "detected with the chicken anti-parkA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0008051:Chicken [Bird]
   753   C0442726:Detected [Finding]
   753   C0677521:Chicken [Food]
   753   C1365945:CHICKEN [Food]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the endogenous parkin band in the anti-sytXI antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not in the preserum control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.91: The specificity of the sytXIA antibody was further confirmed in western blots of protein extracts from PC12 cells (Fig.2B). 

Phrase: "The specificity of the sytXIA antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0003264:Antibody Specificity [Molecular Function]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
   748 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed in western blots of protein"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0521093:confirmed [Qualitative Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1705493:Western [Spatial Concept]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "extracts from PC12 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.92: PC12 cell protein extracts in strong triple detergent buffer were immunoblotted with anti-sytXIA, anti-sytXIA preabsorbed with sytXIA peptide, or with sytXIB peptide. 

Phrase: "PC12 cell protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0085262:PC12 Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "extracts in strong triple detergent buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0205174:Triple [Quantitative Concept]
   753   C0442821:Strong [Qualitative Concept]
   753   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoblotted with anti-sytXIA,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726   C0020985:Immunoblot [Laboratory Procedure]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "anti-sytXIA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "preabsorbed with sytXIA peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "or with sytXIB peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.93: The anti-sytXIA antibody recognized a single band at 64kDa (Fig.2B, lane 1). 

Phrase: "The anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "a single band at 64kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "(Fig.2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.94: The p64 band was not detected when the anti-sytXIA antibody was preabsorbed with the sytXIA peptide (Fig.2B, lane 2), while preabsorption with a different peptide (sytXIB) failed to inhibit the anti-sytXIA immunoreactivity (Fig.2B, lane 3). 

Phrase: "The p64 band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "the anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preabsorbed with the sytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Fig.2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "preabsorption with a different peptide"

Phrase: "(sytXIB"

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the anti-sytXIA immunoreactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig.2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.95: Taken together, these observations further confirm the specificity of the anti-sytXIA antibody. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations further"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of the anti-sytXIA antibody."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   767   C0003264:antibodies specificity [Molecular Function]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]
   714 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.96: Western blots of protein extracts isolated using weak detergent buffer (0.2 or 0.5% NP40 or Triton-X100) gave two sytXI positive bands at 64 and 110kDa, suggesting that sytXI may form homodimers (data not shown). 

Phrase: "Western blots of protein extracts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "weak detergent buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.2"

Phrase: "or"

Phrase: "0.5% NP40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "or"

Phrase: "Triton-X100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146951:Triton X100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "two sytXI positive bands at 64"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "110kDa,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that sytXI"

Phrase: "may"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homodimers"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.97: Parkin interacts with the full-length synaptotagmin XI Co-immunoprecipitation of protein extracts from 293T cells coexpressing the GFPhsytXIAB fusion protein and HAparkin found that parkin co-precipitated the hsytXIAB fragment (data not shown). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with the full-length synaptotagmin XI Co-immunoprecipitation of protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1426106:synaptotagmin XI [Gene or Genome]
   756   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   738   C0021069:Immunoprecipitation [Laboratory Procedure]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0443225:Full [Qualitative Concept]
   738   C1444754:Length [Quantitative Concept]
   738   C1706316:LENGTH [Research Activity]
   738   C1720296:Xi [Intellectual Product]

Phrase: "extracts from 293T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "the GFPhsytXIAB fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "HAparkin"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the hsytXIAB fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: To determine whether parkin interacted with the full-length synaptotagmin, we cloned the full-length synaptotagmin XI cDNA into the pEGFP vector. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacted with the full-length synaptotagmin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443225:Full [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the full-length synaptotagmin XI cDNA into the pEGFP vector."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.99: The pEGFPsytXI construct was individually cotransfected with the pCMVHAparkin plasmid into 293T cells. 

Phrase: "The pEGFPsytXI construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "individually"

Phrase: "cotransfected with the pCMVHAparkin plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "into 293T cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.100: The pEGFP plasmid was used as a vector control. 

Phrase: "The pEGFP plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a vector control."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0031249:vector control [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.101: After 24h, protein extracts were obtained and co-precipitated with mouse anti-GFP antibody to pull down GFP-fusion proteins. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "co-precipitated with mouse anti-GFP antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "to pull down GFP-fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.102: The Co-IP products were immunoblotted with rat anti-HA-conjugated peroxidase (Fig.2C, top panel) or rabbit anti-GFP (Fig.2C, bottom panel). 

Phrase: "The Co-IP products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "immunoblotted with rat anti-HA-conjugated peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   714   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(Fig.2C,"

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "rabbit anti-GFP (Fig.2C,"

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.103: The anti-HA peroxidase detected the HAparkin band only in the sample with GFP-sytXI, but not in the GFP control, suggesting that the HAparkin specifically co-precipitated with the synaptotagmin fusion proteins but not with the GFP tag. 

Phrase: "The anti-HA peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the HAparkin"

Phrase: "band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "only in the sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C0370003:Sample [Substance]
   770   C1720467:Only [Intellectual Product]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "with GFP-sytXI,"

Phrase: "but"

Phrase: "not in the GFP control,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0243148:control [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the HAparkin specifically"

Phrase: "co-precipitated with the synaptotagmin fusion proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "but"

Phrase: "not with the GFP tag."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037293:Tag [Neoplastic Process]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0181496:Tag [Manufactured Object]
   760   C1518422:Not [Functional Concept]
   760   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.104: To determine whether parkin interacted with endogenous sytXI, protein extract from human cerebral cortex was immunoprecipitated with the anti-parkA antibody. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacted with endogenous sytXI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205227:Endogenous [Functional Concept]

Phrase: "protein extract from human cerebral cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "immunoprecipitated with the anti-parkA antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.105: The precipitate was then detected with either chick anti-parkA or anti-sytXIA antibody (Fig.2D, lanes 1 and 2). 

Phrase: "The precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detected with either chick anti-parkA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig.2D, lanes 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1705052:2D [Spatial Concept]
   812   C2986796:2D [Functional Concept]
   779   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.106: The anti-parkA antibody detected a single parkin band in the anti-parkA precipitate (Fig.2D, lane 1, top panel), while the anti-sytXIA antibody detected the sytXI protein band (Fig.2D, lane 1, bottom panel). 

Phrase: "The anti-parkA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a single parkin band in the anti-parkA precipitate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0230715:A band [Cell Component]
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "(Fig.2D, lane 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1705052:2D [Spatial Concept]
   812   C1708639:Lane [Spatial Concept]
   812   C2986796:2D [Functional Concept]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the sytXI protein band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "(Fig.2D, lane 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1705052:2D [Spatial Concept]
   812   C1708639:Lane [Spatial Concept]
   812   C2986796:2D [Functional Concept]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.107: When the same protein extract was co-immunoprecipitated with the anti-sytXI antibody, parkin was specifically coprecipitated with sytXI (Fig.2D, lane 3). 

Phrase: "When"

Phrase: "the same protein extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "co-immunoprecipitated with the anti-sytXI antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "specifically"

Phrase: "coprecipitated with sytXI"

Phrase: "(Fig.2D, lane 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1705052:2D [Spatial Concept]
   812   C1708639:Lane [Spatial Concept]
   812   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.108: The absence of both the sytXI and the parkin bands in the control reactions (Fig.2D, lanes 2 and 4) demonstrated the specificity of the parkinsytXI interactions in the cells, confirming that endogenous parkin interacted with endogenous sytXI. 

Phrase: "The absence of both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "the sytXI"

Phrase: "and"

Phrase: "the parkin bands in the control reactions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0175723:Bands [Medical Device]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "(Fig.2D, lanes 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1705052:2D [Spatial Concept]
   812   C2986796:2D [Functional Concept]
   779   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "the specificity of the parkinsytXI interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "in the cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that endogenous parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacted with endogenous sytXI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205227:Endogenous [Functional Concept]
Processing 00000000.tx.109: The sytXI binding domain is located between amino acid residues 204293 of parkin To determine which domain of parkin binds to synaptotagmin, several truncated parkins tagged with the HA epitope were constructed (Fig.3A). 

Phrase: "The sytXI binding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "located between amino acid residues 204293 of parkin To"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "determine"

Phrase: "which domain of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: "binds to synaptotagmin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "several truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1418270:PARKIN [Gene or Genome]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "tagged with the HA epitope"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0003316:Epitope [Immunologic Factor]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.110: The truncated parkin cDNA expression plasmids expressed sufficient truncated parkins for coexpression with GFP-syts (Fig.3C). 

Phrase: "The truncated parkin cDNA expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressed"

Phrase: "sufficient truncated parkins for coexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1418270:PARKIN [Gene or Genome]
   726   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with GFP-syts"

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.111: Each truncated construct was co-expressed with GFP-sytXI. 

Phrase: "Each truncated construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "co-expressed with GFP-sytXI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.112: After 24h, protein extracts were immunoprecipitated with rat anti-HA-conjugated agarose followed by western blot detection with anti-GFP antibody. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with rat anti-HA-conjugated agarose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0036681:Agarose [Carbohydrate]
   748   C0522529:Conjugated [Spatial Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by western blot detection"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-GFP antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.113: Truncated parkins lacking amino acid residues 204293 (p1203, p294385, and p294465) failed to interact with the full-length synaptotagmin XI. 

Phrase: "Truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "amino acid residues 204293"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(p1203,"

Phrase: "p294385,"

Phrase: "and"

Phrase: "p294465"

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the full-length synaptotagmin XI."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1426106:synaptotagmin XI [Gene or Genome]
   748   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.114: The failure of these truncated parkins to interact with sytXI was not the result of decreased expression levels of the truncated parkins. 

Phrase: "The failure of these truncated parkins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0231174:Failure [Functional Concept]
   748   C0680095:failure [Individual Behavior]

Phrase: "interact with sytXI"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the result of decreased expression levels of the truncated parkins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]
Processing 00000000.tx.115: Expression levels of the p1203 and p294465 parkins were much higher than the constructs that interacted with sytXI (Fig.3C). 

Phrase: "Expression levels of the p1203"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p294465 parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "much higher than the constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "that"

Phrase: "interacted with sytXI"

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: Truncated parkins containing the whole or part of the p204293 domain (p1465, p1314, p78465, p78238, p257465) interacted with sytXI, all having different binding affinities (Fig.3B). 

Phrase: "Truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the whole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444667:Whole [Quantitative Concept]

Phrase: "or"

Phrase: "part of the p204293 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "(p1465,"

Phrase: "p1314,"

Phrase: "p78465,"

Phrase: "p78238,"

Phrase: "p257465"

Phrase: ")"

Phrase: "interacted with sytXI,"

Phrase: "all"

Phrase: "having"

Phrase: "different binding affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.117: These observations suggest that amino acid residues 204293, which contain the RING1 domain, are important for parkin interaction with sytXI. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acid residues 204293,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RING1 domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "important for parkin interaction"

Phrase: "with sytXI."
Processing 00000000.tx.118: View larger version (41K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.119: The sytXI binding site maps to a domain containing the RING1 finger motif. 

Phrase: "The sytXI binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "maps to a domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1706473:Map [Conceptual Entity]
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the RING1 finger motif."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.120: (A) Map of parkin. 

Phrase: "(A)"

Phrase: "Map of parkin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024779:Map [Manufactured Object]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1706473:Map [Conceptual Entity]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.121: Full-length and truncated parkins were constructed by PCR and cloned in-frame with a HAepitope tag; 

Phrase: "Full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "constructed by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   756   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "in-frame with a HAepitope tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080089:Frame [Nucleotide Sequence]
   753   C0180979:Frame [Medical Device]
   753   C1705858:Frame [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.122: C289G and C418R denote parkins containing missense mutation at amino acid positions 289 and 418, respectively. 

Phrase: "C289G"

Phrase: "and"

Phrase: "C418R"

Phrase: "denote"

Phrase: "parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1418270:PARKIN [Gene or Genome]
   966   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "missense mutation at amino acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599155:Missense Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "289"

Phrase: "and"

Phrase: "418,"

Phrase: "respectively."
Processing 00000000.tx.123: (B) The sytXI binding site is mapped to the RING1 motif of the parkin. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The sytXI binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "mapped to the RING1 motif of the parkin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C1418270:PARKIN [Gene or Genome]
   744   C1419389:RING1 [Gene or Genome]
   744   C1514562:Motif [Amino Acid Sequence]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   711   C0024779:Map [Manufactured Object]
   711   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.124: Truncated parkins missing amino acid residues 204293 which encompass the RING1 finger motif fail to bind to sytXI. 

Phrase: "Truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "amino acid residues 204293"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "encompass"

Phrase: "the RING1 finger motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to sytXI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
Processing 00000000.tx.125: The C289G missense mutated parkin interacts weakly with sytXI compared to the C418R mutant. 

Phrase: "The C289G missense"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "weakly with sytXI"

Phrase: "compared to the C418R mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.126: (C) Expression of HA-tagged parkins in HEK293 cells. 

Phrase: "(C) Expression of HA-tagged parkins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.127: Western blot of HEK293 cells overexpressing the full-length wild-type, missense mutated, or various truncated parkins was detected with anti-HA-peroxidase.  

Phrase: "Western blot of HEK293 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the full-length wild-type, missense"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "or"

Phrase: "various truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1418270:PARKIN [Gene or Genome]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "detected with anti-HA-peroxidase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0442726:Detected [Finding]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.128: Data from the binding assays suggest that there are at least two sytXI binding sites on parkin. 

Phrase: "Data from the binding assays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are at least two sytXI binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0005456:Binding Sites [Receptor]
   748   C0205145:Sites [Spatial Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1551058:Are [Quantitative Concept]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "on parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.129: The first binding site is located between amino acid residues 204 and 238. 

Phrase: "The first binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located between amino acid residues 204"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "238."
Processing 00000000.tx.130: This was supported by the observation that the p78238 peptide, which does not contain the RING1 domain, interacted with sytXI while the p1203 peptide did not bind (Fig.3). 

Phrase: "This"

Phrase: "was"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "the p78238 peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RING1 domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "interacted with sytXI"

Phrase: "while"

Phrase: "the p1203 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.131: The second binding site is located within the RING1 domain between amino acid residues 257 and 293. 

Phrase: "The second binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located within the RING1 domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1419389:RING1 [Gene or Genome]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "between amino acid residues 257"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "293."
Processing 00000000.tx.132: This was supported by the observation that peptide p257465 interacted with sytXI, whereas peptides p294385 and p294465 did not bind (Fig.3). 

Phrase: "This"

Phrase: "was"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that peptide p257465"

Phrase: "interacted with sytXI,"

Phrase: "whereas"

Phrase: "peptides p294385"

Phrase: "and"

Phrase: "p294465"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.133: This observation was further supported by the effect of disease-causing amino acid substitutions in parkin. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the effect of disease-causing amino acid substitutions"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   743   C1314792:disease cause [Functional Concept]
   741   C0680963:substitution effect [Functional Concept]
   739   C0001128:Acid [Chemical]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0678227:Causing [Functional Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1521721:Supported [Conceptual Entity]
   739   C2348382:Effect [Qualitative Concept]
   706 E C0015127:cause [Functional Concept]
   706 E C0183683:Support [Medical Device]
   706 E C1524003:Cause [Conceptual Entity]
   706   C1555721:Substitution [Idea or Concept]
   706   C1706204:Substitution [Activity]

Phrase: "in parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.134: Parkin containing a missense mutation in the RING1 finger motif (parkinC289G) interacted weakly with sytXI (2.5-fold less) compared with parkinC418R (Fig.3B). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a missense mutation in the RING1 finger motif"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0599155:Missense Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(parkinC289G"

Phrase: ")"

Phrase: "interacted"

Phrase: "weakly with sytXI"

Phrase: "(2.5-fold less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "compared with parkinC418R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.135: In addition, both mutated parkins fails to ubiquitinate sytXI (Fig.4) although parkinC418R does not lose the ability to bind to sytXI (Fig3B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "both mutated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "sytXI"

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "although"

Phrase: "parkinC418R"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lose"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind to sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(Fig3B"

Phrase: ")."
Processing 00000000.tx.136: View larger version (45K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.137: Parkin ubiquitinates sytXI. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "sytXI."
Processing 00000000.tx.138: HEK293 cells overexpressing HA-parkins or controls with the corresponding myc-ubiquitin and GFP-tagged proteins were treated with lactacystin for 4h, and protein extracts were immunoprecipitated with anti-GFP antibody. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "HA-parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "controls with the corresponding myc-ubiquitin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "GFP-tagged proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "treated with lactacystin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0125179:lactacystin [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 4h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "and"

Phrase: "protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-GFP antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.139: IP products of the ubiquitination assays were detected with an antibody to the myc tag (A) and anti-GFP antibody (B). 

Phrase: "IP products of the ubiquitination assays"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "detected with an antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "to the myc tag ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "A)"

Phrase: "and"

Phrase: "anti-GFP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.140: Note the lack of ubiquitinated products in cells expressing HA-parkin and GFP, and the undetectable level of ubiquitination of GFPsytXI in other controls. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the lack of ubiquitinated products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "HA-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the undetectable level of ubiquitination of GFPsytXI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in other controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.141: Cells expressing parkin mutants and GFPsytXI produce a lower amount of ubiquitin-conjugated sytXI compared with the wild-type parkin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "parkin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "GFPsytXI"

Phrase: "produce"

Phrase: "a lower amount of ubiquitin-conjugated sytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "compared with the wild-type parkin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.142: The anti-GFP antibody detects near equal amounts of GFP-sytXI monomer in all samples containing GFP-sytXI and a large GFPsytXI band near the well containing the sample co-expressed with both GFPsytXI and HAparkin. 

Phrase: "The anti-GFP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detects near equal amounts of GFP-sytXI monomer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0205163:Equal [Qualitative Concept]
   744   C0442726:detect [Finding]
   744   C0596973:Monomer [Chemical Viewed Structurally]
   744   C1265611:amounts [Quantitative Concept]
   744   C1549782:Equal [Idea or Concept]

Phrase: "in all samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "GFP-sytXI"

Phrase: "and"

Phrase: "a large GFPsytXI band near the well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0230715:A band [Cell Component]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "co-expressed with both GFPsytXI"

Phrase: "and"

Phrase: "HAparkin."
Processing 00000000.tx.143: (C) Western blot of the same lysate with anti-HA antibody indicates that the truncated and mutated parkins are expressed at higher levels than wild-type parkin.  

Phrase: "(C) Western blot of the same lysate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicates"

Phrase: "that"

Phrase: "the truncated"

Phrase: "and"

Phrase: "mutated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "expressed at higher levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0441889:Levels [Qualitative Concept]
   737   C0205250:High [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737   C1299351:High [Qualitative Concept]
   737 E C1547707:Level [Geographic Area]
   737   C2700149:HIGH [Intellectual Product]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "than wild-type parkin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.144: Ubiquitination and degradation of synaptotagmin XI by parkin Parkin is an E3 ubiquitin ligase, an essential enzyme required for the ubiquitination of specific substrates targeted for degradation by the proteasome complex or the lysosome (14,17). 

Phrase: "Ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation of synaptotagmin XI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by parkin Parkin"

Phrase: "is"

Phrase: "an E3 ubiquitin ligase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an essential enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "required for the ubiquitination of specific substrates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205369:Specific [Qualitative Concept]
   748   C1514873:Required [Functional Concept]
   748   C1519751:Ubiquitination [Molecular Function]
   748   C1552740:specific [Intellectual Product]
   714   C1710236:Substrate [Manufactured Object]

Phrase: "targeted for degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "by the proteasome complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "the lysosome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024369:Lysosome [Cell Component]
  1000   C2984253:Lysosome [Functional Concept]
   928 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(14,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.145: To determine whether sytXI is a substrate of parkin, we performed semi-quantitative in vitro ubiquitination assays as described by Zhang et al. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "sytXI"

Phrase: "is"

Phrase: "a substrate of parkin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "semi-quantitative in vitro ubiquitination assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   850   C1515653:In Vitro Assay [Research Activity]
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described by Zhang et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.146: (17) . In these experiments, HEK293 cells were cotransfected with various combinations of HA-tagged parkin cDNA plasmid or controls, myc-tagged ubiquitin, and GFP-tagged sytXI (Fig.4). 

Phrase: "(17"

Phrase: ") ."

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cotransfected with various combinations of HA-tagged parkin cDNA plasmid"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   739   C0453882:Combinations [Manufactured Object]
   739   C1418270:PARKIN [Gene or Genome]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1708632:Tagged [Qualitative Concept]
   739   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C0205195:Combination [Qualitative Concept]
   706 E C1710492:TAG [Gene or Genome]
   706 E C1947911:Combination [Physical Object]

Phrase: "or"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "myc-tagged ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GFP-tagged sytXI"

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.147: GFP was used as a negative control for substrate specificity, while truncated HA-tagged parkin proteins (p78465, p1203, p294385, p294465) were used as mutant parkin negative controls. 

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "used as a negative control"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for substrate specificity,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "while"

Phrase: "truncated HA-tagged parkin proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(p78465,"

Phrase: "p1203,"

Phrase: "p294385,"

Phrase: "p294465"

Phrase: ")"

Phrase: "were"

Phrase: "used as mutant parkin negative controls."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   756   C1639518:% negative control [Quantitative Concept]
   756   C1947986:Negative Control [Conceptual Entity]
   753   C0205160:Negative [Qualitative Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1273517:used [Finding]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0042153:use [Functional Concept]
   719   C0243148:control [Qualitative Concept]
   719 E C0457083:Use [Functional Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719 E C1947944:Use [Intellectual Product]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.148: As shown in Figure 4, when cells were incubated with lactacystin, an inhibitor of the proteasome complex, cells expressing the wild-type parkin and GFPsytXI showed an accumulation of ubiquitin-synaptotagmin conjugates above background controls. 

Phrase: "As"

Phrase: "shown in Figure 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with lactacystin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0125179:lactacystin [Antibiotic,Organic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "an inhibitor of the proteasome complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   783   C2266856:Proteasome Inhibitor [Molecular Function]
   783   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the wild-type parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "GFPsytXI"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an accumulation of ubiquitin-synaptotagmin"

Phrase: "conjugates above background controls."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0301869:Conjugate [Immunologic Factor]
   770   C1706907:Background [Conceptual Entity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.149: Wild-type parkin had no effect on the polyubiquitination of the GFP tag. 

Phrase: "Wild-type parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "had"

Phrase: "no effect on the polyubiquitination of the GFP tag."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.150: Truncated parkins showed little effect on the levels of ubiquitinated synaptotagmin conjugates, although one of the peptides (p78465) could bind to sytXI (Fig.3), and the levels of expression of the truncated parkins were high compared with the wild-type parkin. 

Phrase: "Truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "little effect on the levels of ubiquitinated synaptotagmin conjugates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "although"

Phrase: "one of the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "(p78465"

Phrase: ")"

Phrase: "could"

Phrase: "bind to sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the levels of expression of the truncated parkins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "compared with the wild-type parkin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.151: The pattern of ubiquitinated syts suggested the presence of a variety of species containing polyubiquitin chains of different lengths. 

Phrase: "The pattern of ubiquitinated syts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a variety of species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "polyubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0084133:Polyubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421267:POLYUBIQUITIN [Gene or Genome]

Phrase: "chains of different lengths."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0337112:Chain [Manufactured Object]
   770   C1444754:Lengths [Quantitative Concept]
   770   C1524075:Chain [Idea or Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C1706316:LENGTH [Research Activity]
Processing 00000000.tx.152: To determine whether disease-associated point mutations affected the ability to ubiquitinate sytXI, ubiquitination assays were also performed for missense mutated parkinC289G and parkinC418R. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "disease-associated point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   812   C0026882:Mutations [Genetic Function]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "ubiquitinate"

Phrase: "sytXI,"

Phrase: "ubiquitination assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "performed for missense"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "parkinC289G"

Phrase: "and"

Phrase: "parkinC418R."
Processing 00000000.tx.153: Both mutant parkins produced undetectable levels of ubiquitinated sytXI compared with the wild-type parkin (Fig.4). 

Phrase: "Both mutant parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "produced"

Phrase: "undetectable levels of ubiquitinated sytXI"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with the wild-type parkin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.154: Under longer exposure, all truncated and missense mutated parkin transfected cells produced weak levels of ubiquitin-conjugated sytXI comparable to cells transfected with only GFP-sytXI, but the levels of the ubiquitinated sytXI were significantly lower than those produced by wild-type parkin (data not shown). 

Phrase: "Under longer exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "all"

Phrase: "truncated"

Phrase: "and"

Phrase: "missense"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "parkin transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "produced"

Phrase: "weak levels of ubiquitin-conjugated sytXI"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "comparable to cells"

Phrase: "transfected with only GFP-sytXI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "the levels of the ubiquitinated sytXI"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "produced by wild-type parkin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: This background level of ubiquitinated sytXI was probably produced by endogenous parkin or by an unidentified E3 ubiquitin ligase in HEK293 cells, and are consistent with observations by other investigators using HEK293 cells (28). 

Phrase: "This background level of ubiquitinated sytXI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1706907:Background [Conceptual Entity]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "produced by endogenous parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205227:Endogenous [Functional Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or by an unidentified E3 ubiquitin ligase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   814   C1418270:E3 ubiquitin ligase [Gene or Genome]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205427:Unidentified [Qualitative Concept]
   748   C1537525:E3 [Gene or Genome]

Phrase: "in HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "consistent with observations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "by other investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.156: In both co-ip (Fig.3) and ubiquitination (Fig.4) experiments, a majority of mutant parkins could be detected in the pellet fractions that were dissolved in the SDSPAGE sample buffer. 

Phrase: "In both"

Phrase: "co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "a majority of mutant parkins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "could"

Phrase: "be"

Phrase: "detected in the pellet fractions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0441436:Pellet [Manufactured Object]
   760   C0442726:Detected [Finding]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1998480:Pellet [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "were"

Phrase: "dissolved in the SDSPAGE sample buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   719   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.157: Western blot analysis of the same protein samples with an anti-GFP antibody detected a high MW GFPsytXI band near the top of the well loaded with the parkinsytXI co-expressed sample (Fig.4). 

Phrase: "Western blot analysis of the same protein samples"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   750   C1303103:Sample analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "with an anti-GFP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a high MW GFPsytXI band near the top of the well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0230715:A band [Cell Component]
   738   C0175723:Band [Medical Device]
   738   C0439645:Band [Spatial Concept]
   738   C1521913:band [Cell Component]

Phrase: "loaded with the parkinsytXI"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "co-expressed"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: This band was likely the insoluble ubiquitinylated sytXI complex since the anti-myc antibody also strongly detected the same complex. 

Phrase: "This band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "the insoluble ubiquitinylated sytXI complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "since"

Phrase: "the anti-myc antibody also strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the same complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.159: This band was faintly observed in the controls. 

Phrase: "This band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "faintly"

Phrase: "observed in the controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1441672:Observed [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.160: The smaller MW ubiquitinylated sytXI species were undetectable by the antiGFP antibody. 

Phrase: "The smaller MW ubiquitinylated sytXI species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "undetectable by the antiGFP antibody."
Processing 00000000.tx.161: These findings are consistent with ubiquitinylation experiments of - and -tubulin (28) and synphilin-1 (24) in HEK293 cells. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with ubiquitinylation experiments of -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(24"

Phrase: ")"

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: In these experiments, the ubiquitinylated substrates were undetectable by the antibodies against the respective proteins, but the antibodies against ubiquitin or its tag strongly detected the respective parkin-mediated ubiquitinylated substrates. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the ubiquitinylated substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "undetectable by the antibodies"

Phrase: "against the respective proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "the antibodies against ubiquitin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "its tag strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the respective parkin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "ubiquitinylated substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.163: Since parkin-mediated ubiquitinylated substrates undergo degradation by the proteasome-dependent pathway (17,22,25,28,29,32), we performed pulse-chase experiments to determine the turnover of GFPsytXI in HAvector and HAparkin1-465 transfected HEK293 cells. 

Phrase: "Since"

Phrase: "parkin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "ubiquitinylated substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "undergo"

Phrase: "degradation by the proteasome-dependent pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1511758:Degradation Pathway [Conceptual Entity]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "(17,"

Phrase: "22,"

Phrase: "25,"

Phrase: "28,"

Phrase: "29,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pulse-chase experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "determine"

Phrase: "the turnover of GFPsytXI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]

Phrase: "in HAvector"

Phrase: "and"

Phrase: "HAparkin1-465 transfected HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C2936239:HEK293 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Parkin increased the degradation of GFPsytXI in HAparkin1465 transfected HEK293 cells (Fig.5). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the degradation of GFPsytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in HAparkin1465"

Phrase: "transfected"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: Approximately 40% of newly synthesized GFP-sytXI was degraded after 1.5h chase in HAparkin1-465 expressing cells, whereas it took 3h to degrade the equivalent amount of GFPsytXI in HAvector transfected cells. 

Phrase: "Approximately 40% of newly synthesized GFP-sytXI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0332232:Approximately [Qualitative Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C0750546:newly [Idea or Concept]
   748   C1883254:Synthesized [Activity]

Phrase: "was"

Phrase: "degraded after 1.5h chase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1442467:5H [Temporal Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in HAparkin1-465 expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "it"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "3h to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "degrade"

Phrase: "the equivalent amount of GFPsytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in HAvector transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.166: View larger version (24K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.167: Parkin accelerates the turnover of GFPsytXI. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the turnover of GFPsytXI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.168: Pulse-chase analysis of the degradation of GFPsytXI in HEK293 cells expressing either HA-vector or HA-parkin at 0, 1.5, 3, 6 and 24h. 

Phrase: "Pulse-chase analysis of the degradation of GFPsytXI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "either HA-vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "or"

Phrase: "HA-parkin at 0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6"

Phrase: "and"

Phrase: "24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.169: Data are from one of two independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are from one of two independent experiments."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   774   C0332291:Independent of [Functional Concept]
   748   C0085862:Independent [Idea or Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0681814:Experiments [Research Activity]
   748   C1299583:Independent [Finding]
   748   C1551058:Are [Quantitative Concept]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.170: The second experiment (not shown) had even stronger parkin effect.  

Phrase: "The second experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "had"

Phrase: "even stronger parkin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.171: Parkin colocalizes with synaptotagmin XI The interaction of two proteins is likely to be physiologically relevant if they occupy the same subcellular compartment. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "colocalizes with synaptotagmin XI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1426106:synaptotagmin XI [Gene or Genome]
   770   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1720296:Xi [Intellectual Product]

Phrase: "The interaction of two proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0872079:interaction protein [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "physiologically relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "if"

Phrase: "they"

Phrase: "occupy"

Phrase: "the same subcellular compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.172: To investigate parkinsyt co-localization, we induced non-transfected PC12 cells with NGF for 7 days, and co-labeled the NGF-induced PC12 neuron-like cells with chick anti-parkA and rabbit anti-syt XIA (Fig.6AC). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "parkinsyt co-localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "we"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "non-transfected PC12 cells with NGF"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0085262:PC12 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "for 7 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "co-"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "the NGF-induced PC12 neuron-like cells with chick anti-parkA"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   754   C0085262:PC12 Cells [Cell]
   738   C0007634:Cells [Cell]
           THE CELL
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rabbit anti-syt XIA"

Phrase: "(Fig.6AC"

Phrase: ")."
Processing 00000000.tx.173: Parkin co-localized with sytXI at positions around the nuclear membrane and at boutons (Fig.6C, white arrows) along the neurites. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-localized with sytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:Localized [Spatial Concept]

Phrase: "at positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "around the nuclear membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028584:Nuclear Membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and at boutons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   756   C0206181:bouton [Cell Component]

Phrase: "(Fig.6C,"

Phrase: "white arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "along the neurites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurites [Cell Component]
Processing 00000000.tx.174: Parkin or sytXI present in other regions of the cell did not co-localize. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "sytXI present in other regions of the cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-localize."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localize [Spatial Concept]
Processing 00000000.tx.175: The co-localization of parkin and sytXI was further confirmed with immunohistochemical labeling of human substantia nigra neurons (Fig.6DL). 

Phrase: "The co-localization of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "sytXI"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed with immunohistochemical labeling of human substantia nigra neurons"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   764   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0086418:Human [Human]
   742   C0521093:confirmed [Qualitative Concept]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1167624:Labeling [Mental Process]
   742   C1441616:Immunohistochemical [Laboratory Procedure]
   742   C1947902:Labeling [Manufactured Object]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   708 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig.6DL"

Phrase: ")."
Processing 00000000.tx.176: Both parkin and sytXI proteins had similar distribution patterns in the cytoplasm and neurites of the human nigral neurons. 

Phrase: "Both parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sytXI proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "similar distribution patterns in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:distribution patterns [Spatial Concept]
   753   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "neurites of the human nigral neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085103:Neurites [Cell Component]
Processing 00000000.tx.177: Parkin and sytXI were also co-localized in HEK293 cells co-expressing HA-parkin and GFP-sytXI (data not shown). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sytXI"

Phrase: "were"

Phrase: "also"

Phrase: "co-localized in HEK293 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0392752:Localized [Spatial Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "HA-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GFP-sytXI"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: View larger version (102K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(102K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.179: Subcellular distribution of endogenous synaptotagmin XI in nontransfected PC12 cells and human substantia nigra neurons. 

Phrase: "Subcellular distribution of endogenous synaptotagmin XI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in nontransfected PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "human substantia nigra neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.180: (AC) Endogenous parkin co-localizes with endogenous sytXI in NGF-induced PC12 cells. 

Phrase: "(AC) Endogenous parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-localizes with endogenous sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205227:Endogenous [Functional Concept]
   760   C0392752:localize [Spatial Concept]

Phrase: "in NGF-induced PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.181: PC12 cells were induced with 50ng/ml NGF for 7 days, and immunofluorescently co-labeled with antibodies to parkin (green, A) and sytXI (red, B). 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced with 50ng/ml NGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205263:Induced [Functional Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C1417719:NGF [Gene or Genome]

Phrase: "for 7 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "immunofluorescently co-"

Phrase: "labeled with antibodies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "to parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "A)"

Phrase: "and"

Phrase: "sytXI"

Phrase: "(red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.182: Images were acquired by Leica TCSSP microscopy using a 100x oil immersion lens. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired by Leica TCSSP microscopy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0439661:Acquired [Temporal Concept]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 100x oil immersion lens."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0023317:Lens [Body Part, Organ, or Organ Component]
   812   C0023318:Lens [Medical Device]
   812   C0996842:Lens [Plant]
   812   C1278892:Lens [Body Part, Organ, or Organ Component]
Processing 00000000.tx.183: Stacked images were merged (C). 

Phrase: "Stacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3272897:Stack [Spatial Concept]

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "merged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881786:Merged [Activity]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.184: Yellow indicates co-localization of two proteins. 

Phrase: "Yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: "indicates"

Phrase: "co-localization of two proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0597704:protein localisation [Cell Function]
   781   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.185: Inserts show the cell body of the same cell from which the long neurite arises. 

Phrase: "Inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0813036:Inserts [Medical Device]
   966 E C0441587:Insert [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the cell body of the same cell"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007634:THE CELL [Cell]
           Cell
   778   C0599444:Cell body [Cell Component]
   778   C2752549:cell body [Cell Component]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "from which"

Phrase: "the long neurite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurite [Cell Component]

Phrase: "arises."
Processing 00000000.tx.186: Parkin and sytXI co-localize in the perinuclear area and boutons (arrows) along the neurite. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sytXI"

Phrase: "co-localize in the perinuclear area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]
   753   C0392752:localize [Spatial Concept]

Phrase: "and"

Phrase: "boutons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206181:bouton [Cell Component]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "along the neurite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurite [Cell Component]
Processing 00000000.tx.187: (DL) Distribution of synaptotagmin XI and parkin in a normal human substantia nigra section. 

Phrase: "(DL) Distribution of synaptotagmin XI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "parkin in a normal human substantia nigra section."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1418270:PARKIN [Gene or Genome]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.188: Human substantia nigra sections were labeled with the rabbit anti-sytXIA antibody (D, G, J), anti-sytXIA antibody preabsorbed with 100xsytXIA peptide (E, H, K), or rabbit anti-parkA antibody (F, I, L). 

Phrase: "Human substantia nigra sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "labeled with the rabbit anti-sytXIA antibody"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0034493:Rabbit [Mammal]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "J"

Phrase: ")"

Phrase: ","

Phrase: "anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "preabsorbed with 100xsytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(E,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "rabbit anti-parkA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "L)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.189: Images show the cell bodies and neurites of dopaminergic neurons in the substantia nigra. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the cell bodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   966   C0599444:Cell body [Cell Component]
   966   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:bodies [Human]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "neurites of dopaminergic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085103:Neurites [Cell Component]

Phrase: "in the substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.190: (MO) Adjacent PD brain sections labeled with rabbit anti-ubiquitin (M), anti-sytXIA (N), and anti-sytXIA+sytXIA peptide (O); 

Phrase: "(MO) Adjacent PD brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "labeled with rabbit anti-ubiquitin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0034493:Rabbit [Mammal]
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "("

Phrase: "M)"

Phrase: ","

Phrase: "anti-sytXIA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(N),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "anti-sytXIA+sytXIA peptide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.191: black arrows point to Lewy bodies. 

Phrase: "black arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "point to Lewy bodies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1552961:Point [Quantitative Concept]
   770   C1995017:Bodies [Cell Component]
   770   C2347617:point [Quantitative Concept]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.192: Note the absence of Lewy body labeling by preabsorbed sytXIA antibody. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the absence of Lewy body labeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "by preabsorbed sytXIA antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.193: Images were acquired using a 20x lens (DF), and 63x oil immersion lens (GO).  

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 20x lens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023317:Lens [Body Part, Organ, or Organ Component]
   861   C0023318:Lens [Medical Device]
   861   C0996842:Lens [Plant]
   861   C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "(DF"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "63x oil immersion lens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0023317:Lens [Body Part, Organ, or Organ Component]
   812   C0023318:Lens [Medical Device]
   812   C0996842:Lens [Plant]
   812   C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "GO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.194: SytXI is localized in the cell bodies and neurites of human substantia nigra neurons The death of substantia nigra neurons and the formation of Lewy bodies are hallmarks of many forms of PD, and some constituent proteins of Lewy bodies are mutated in inherited forms of PD. 

Phrase: "SytXI"

Phrase: "is"

Phrase: "localized in the cell bodies"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C0599444:bodies cell [Cell Component]
   773 E C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:bodies [Human]
   760   C0392752:Localized [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "neurites of human substantia nigra neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085103:Neurites [Cell Component]

Phrase: "The death of substantia nigra neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2754100:neuron death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "the formation of Lewy bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "hallmarks of many forms of PD,"

Phrase: "and"

Phrase: "some constituent proteins of Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1325683:protein body [Cell Component]

Phrase: "are"

Phrase: "mutated in inherited forms of PD."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C0439660:Inherited [Functional Concept]
   753   C1705285:Mutated [Cell or Molecular Dysfunction]
   719 E C1513776:Mutate [Genetic Function]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.195: To establish a potential link between sytXI and parkin in the pathogenesis of neurodegeneration in classic PD, we performed immunohistochemical labeling of substantia nigra sections from two normal and two sporadic PD patients using antibodies to sytXI (anti-sytXIA), parkin and ubiquitin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a potential link between sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "parkin in the pathogenesis of neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in classic PD,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunohistochemical labeling of substantia nigra sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "from two normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "two sporadic PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to sytXI (anti-sytXIA),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.196: As shown in Figure6, the normal human substantia nigra neurons were strongly stained by antibodies to sytXI and parkin. 

Phrase: "As"

Phrase: "shown in Figure6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "the normal human substantia nigra neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "strongly"

Phrase: "stained by antibodies to sytXI"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.197: The anti-sytXIA antibody labeled both the cell bodies and neurite extensions of the nigral neurons (Fig.6D, G and J) similar to the anti-parkA antibody (Fig.6F, I and L). 

Phrase: "The anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "both the cell bodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   966   C0599444:Cell body [Cell Component]
   966   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:bodies [Human]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "neurite extensions of the nigral neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0231448:extensions [Functional Concept]
   719 E C1880641:Extension [Conceptual Entity]

Phrase: "(Fig.6D,"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "J)"

Phrase: "similar to the anti-parkA antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig.6F,"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "L)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.198: The sytXI immunoreactivities were specific, since anti-sytXIA preabsorbed with the sytXIA peptide failed to label the nigral neurons (Fig.6E, H and K). 

Phrase: "The sytXI immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "were"

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "since"

Phrase: "anti-sytXIA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "preabsorbed with the sytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "failed to label"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0181496:Label [Manufactured Object]
   790   C0231175:Failed [Functional Concept]
   790   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "the nigral neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig.6E,"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: Figure 6MO depicts the immunohistochemical labeling of a nigral neuron from an individual with sporadic PD. 

Phrase: "Figure 6MO"

Phrase: "depicts"

Phrase: "the immunohistochemical labeling of a nigral neuron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1167624:Labeling [Mental Process]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "from an individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "with sporadic PD."
Processing 00000000.tx.200: The anti-sytXIA antibody labeled the core of the intracellular Lewy bodies (LBs; Fig.6N, black arrow) similar to the anti-ubiquitin antibody (Fig.6M). 

Phrase: "The anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "the core of the intracellular Lewy bodies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   788   C3546702:Lewy body core [Cell Component]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "(LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439219:lbs [Quantitative Concept]
  1000   C3161851:LBS [Laboratory Procedure]

Phrase: "; Fig.6N,"

Phrase: "black arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "similar to the anti-ubiquitin antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig.6M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3171719:6M [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.201: The sytXI LBs staining was weak compared with ubiquitin staining; 

Phrase: "The sytXI LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439219:lbs [Quantitative Concept]
   861   C3161851:LBS [Laboratory Procedure]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004093:Weak [Sign or Symptom]
  1000   C1762617:Weak [Qualitative Concept]

Phrase: "compared with ubiquitin staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1707455:Compared [Activity]

Phrase: ";"
Processing 00000000.tx.202: of note is the strong labeling of the neuropil. 

Phrase: "of note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "the strong labeling of the neuropil."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.203: This labeling was specific since anti-sytXIA antibody preabsorbed with the sytXIA peptide failed to label the Lewy body or the neuropil (Fig.6O, black arrow). 

Phrase: "This labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "since"

Phrase: "anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "preabsorbed with the sytXIA peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "failed to label"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0181496:Label [Manufactured Object]
   790   C0231175:Failed [Functional Concept]
   790   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "the Lewy body"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085200:Lewy Body [Cell Component]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "or"

Phrase: "the neuropil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228081:Neuropil [Cell Component]

Phrase: "(Fig.6O,"

Phrase: "black arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.204: As the authors and others reported previously (33), the Lewy bodies in these two sporadic PD brains did not stain with the anti-parkA antibody (data not shown).  

Phrase: "As the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "the Lewy bodies in these two sporadic PD brains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C0085200:Lewy Bodies [Cell Component]
   742   C0242821:bodies [Human]
   742   C1995017:Bodies [Cell Component]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stain with the anti-parkA antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Our finding that parkin can directly interact with and ubiquitinate synaptotagmin XI strongly implicates parkin in a role of modifying synaptic vesicle trafficking at the presynaptic terminal. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "interact with"

Phrase: "and"

Phrase: "ubiquitinate synaptotagmin XI strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1426106:synaptotagmin XI [Gene or Genome]
   812   C1720296:Xi [Intellectual Product]

Phrase: "implicates"

Phrase: "parkin in a role of modifying synaptic vesicle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1418270:PARKIN [Gene or Genome]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "trafficking at the presynaptic terminal."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0206181:Presynaptic Terminal [Cell Component]
   760   C0205088:Terminal [Temporal Concept]
   760   C0599896:trafficking [Cell Function]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.206: Among the parkin interactors, two proteins, CDCrel-1 and synphilin-1 (3436), are synaptic vesicle-associated proteins. 

Phrase: "Among the parkin interactors,"

Phrase: "two proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(3436"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "synaptic vesicle-associated proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.207: CDCrel-1 interacts with syntaxin, and overexpression of wild-type CDCrel-1 inhibits secretion in HIT-T15 cells (36). 

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "interacts with syntaxin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "overexpression of wild-type CDCrel-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretion in HIT-T15 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1327616:Cell secretion [Cell Function]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.208: Synphilin-1 interacts with -synuclein and stimulates the formation of cytosolic inclusion bodies (32). 

Phrase: "Synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "interacts with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "stimulates"

Phrase: "the formation of cytosolic inclusion bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.209: The presence of wild-type parkin appears to be essential for synphilin-1-induced formation of the Lewy bodies. 

Phrase: "The presence of wild-type parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "essential for synphilin-1-induced formation of the Lewy bodies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.210: It is currently unknown how CDCrel-1 or synphilin-1 participates in the regulation of presynaptic neurotransmission, and it is also unclear whether CDCrel-1 or synphilin-1 plays any role in the regulation of presynaptic secretion of dopamine. 

Phrase: "It"

Phrase: "is"

Phrase: "currently unknown how CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   840   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   804   C1539748:CDCREL [Gene or Genome]

Phrase: "or"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "participates in the regulation of presynaptic neurotransmission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0027793:Neurotransmission [Cell Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "also unclear"

Phrase: "whether"

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "or"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "any role in the regulation of presynaptic secretion of dopamine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.211: Synaptotagmin XI is a member of a large family of 50 calcium-binding proteins with high homology at the C2A and C2B domains. 

Phrase: "Synaptotagmin XI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]

Phrase: "is"

Phrase: "a member of a large family of 50 calcium-binding proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0424972:Member of large family [Family Group]
   754   C0086282:Family member [Family Group]
   754   C1611821:Family Member [Intellectual Product]
   738   C0680022:member [Population Group]
   738   C2698041:Member [Professional or Occupational Group]

Phrase: "with high homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334043:Homology [Gene or Genome]
   861   C2697616:Homology [Qualitative Concept]

Phrase: "at the C2A"

Phrase: "and"

Phrase: "C2B domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.212: These proteins include synaptotagmins IXIII, raphilin-2a, protein kinase C, GTPase-activating protein (GAP), rat/yeast ubiquitin ligase Nedd4, and phospholipaseA. 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "synaptotagmins IXIII,"

Phrase: "raphilin-2a,"

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "GTPase-activating protein (GAP),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0061928:GTPase-Activating Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419277:GTPase-ACTIVATING PROTEIN [Gene or Genome]
  1000   C2984553:GTPase-Activating Protein [Amino Acid, Peptide, or Protein]
   827   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: "rat/yeast ubiquitin ligase Nedd4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417659:NEDD4 [Gene or Genome]

Phrase: "and"

Phrase: "phospholipaseA."
Processing 00000000.tx.213: Together, these proteins serve a common function as regulators of cell signal transduction ranging from calcium sensors (syts and protein kinase C) to phosphorylation (GAP) and phospholipid degradation (phospholipase C). 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "serve"

Phrase: "a common function as regulators of cell signal transduction ranging"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   777   C0037083:Signal transduction, function [Cell Function]
   757   C0007613:Cell Function [Cell Function]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]

Phrase: "from calcium sensors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0183210:sensors [Medical Device]
   827 E C1705193:Sensor [Manufactured Object]

Phrase: "(syts"

Phrase: "and"

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "to phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(GAP"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0061928:GTPase-Activating Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419277:GTPase-ACTIVATING PROTEIN [Gene or Genome]
  1000   C2984553:GTPase-Activating Protein [Amino Acid, Peptide, or Protein]
   827   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "phospholipid degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157950:phospholipid degradation [Molecular Function]
  1000   C1519056:Phospholipid Degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(phospholipase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.214: Among the synaptotagmins, sytI has the highest homology with sytII, and it is expressed abundantly in synaptic vesicles and secretory granules (37). 

Phrase: "Among the synaptotagmins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0084697:Synaptotagmins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sytI"

Phrase: "has"

Phrase: "the highest homology with sytII,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "expressed"

Phrase: "abundantly in synaptic vesicles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.215: SytI and sytII function as calcium sensors in fast presynaptic neurotransmission (38,39) similar to sytIII, VVII, and X. 

Phrase: "SytI"

Phrase: "and"

Phrase: "sytII function as calcium sensors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in fast presynaptic neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027793:Neurotransmission [Cell Function]

Phrase: "(38,"

Phrase: "39"

Phrase: ")"

Phrase: "similar to sytIII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "VVII,"

Phrase: "and"

Phrase: "X."
Processing 00000000.tx.216: Synaptotagmin XI, in contrast, is similar to sytIV owing to a conserved substitution of an aspartate by a serine residue in the C2A domain resulting in lack of Ca+2 binding to this domain (40). 

Phrase: "Synaptotagmin XI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "is"

Phrase: "similar to sytIV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "owing to a conserved substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "of an aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by a serine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "in the C2A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "resulting in lack of Ca+2 binding"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0332294:Resulting in [Functional Concept]
   778   C0596235:CA+2 [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C0332268:lack [Qualitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "to this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.217: SytXI is predominantly expressed in the brain (40). 

Phrase: "SytXI"

Phrase: "is"

Phrase: "predominantly"

Phrase: "expressed in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.218: The functions of most synaptotagmins are currently speculative, although sytXI is thought to function as a down-regulator of fast presynaptic neurotransmission (41). 

Phrase: "The functions of most synaptotagmins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "currently speculative,"

Phrase: "although"

Phrase: "sytXI"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as a down-regulator of fast presynaptic neurotransmission"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0015663:Fast [Finding]
   742   C0027793:Neurotransmission [Cell Function]
   742   C0031843:function [Physiologic Function]
   742   C0182953:REGULATOR [Medical Device]
   742   C0456962:Fast [Qualitative Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]
   742   C1705273:Function [Intellectual Product]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.219: Overall, members of the syt family have high homology at the C2 domains with amino acid identity ranging from 30 to 50%. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "members of the syt family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "high homology at the C2 domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]

Phrase: "with amino acid identity ranging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1514721:Range [Quantitative Concept]
   779   C2348147:Range [Quantitative Concept]
   779   C3542016:Range [Intellectual Product]

Phrase: "from 30"

Phrase: "to 50%."
Processing 00000000.tx.220: Since parkin binds to the C2A and C2B domains of sytXI, it is likely that parkin interacts with other syts as well. 

Phrase: "Since"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "binds to the C2A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "C2B domains of sytXI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with other syts"

Phrase: "as well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.221: The observation that parkin also interacts with and regulates sytI (Huynh, D.P. et al., manuscript in preparation), a protein that contains the lowest C2 domain homology with sytXI (30% identity), suggests that parkin may interact with a wide range of proteins containing domains related to the C2A and C2B sequences. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that parkin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with"

Phrase: "and"

Phrase: "regulates"

Phrase: "sytI"

Phrase: "(Huynh,"

Phrase: "D.P. et al.,"

Phrase: "manuscript in preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the lowest C2 domain homology with sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]

Phrase: "(30% identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "interact with a wide range of proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332464:Wide [Spatial Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "related to the C2A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "C2B sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.222: SytXI is found in the central core of LBs in substantia nigra neurons from patients with idiopathic PD (Fig.6). 

Phrase: "SytXI"

Phrase: "is"

Phrase: "found in the central core of LBs"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0333763:central core [Cell Component]
   748   C0150312:Found [Quantitative Concept]
   748   C0205099:Central [Spatial Concept]
   748   C0439219:lbs [Quantitative Concept]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1879652:Central - [Laboratory Procedure]
   748   C1882467:Core [Manufactured Object]
   748   C3161851:LBS [Laboratory Procedure]
   748   C3274653:Core [Body Substance]
   714 E C0243095:Find [Finding]

Phrase: "in substantia nigra neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   734   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with idiopathic PD (Fig.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332240:Idiopathic [Functional Concept]
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.223: This distribution is also observed for other parkin substrates, p38 subunit of the aminoacyl tRNA synthetase complex and synphilin-1 (29,42,43). 

Phrase: "This distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "observed for other parkin substrates,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1418270:PARKIN [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726   C1710236:Substrate [Manufactured Object]

Phrase: "p38 subunit of the aminoacyl tRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(29,"

Phrase: "42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.224: The finding of sytXI in LBs suggests a potential link of abnormal processing of synaptotagmins in PD. 

Phrase: "The finding of sytXI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "in LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439219:lbs [Quantitative Concept]
  1000   C3161851:LBS [Laboratory Procedure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a potential link of abnormal processing of synaptotagmins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1517892:Link [Intellectual Product]
   744   C1704666:Link [Intellectual Product]

Phrase: "in PD."
Processing 00000000.tx.225: Whether LBs play a role in dopaminergic neuronal death in Parkinsonism is speculative. 

Phrase: "Whether"

Phrase: "LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439219:lbs [Quantitative Concept]
  1000   C3161851:LBS [Laboratory Procedure]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in dopaminergic neuronal death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "is"

Phrase: "speculative."
Processing 00000000.tx.226: The absence of LBs in parkin-associated parkinsonism (4446) implies that these inclusions are not the primary cause of dopaminergic neuronal degeneration in parkin-associated parkinsonism. 

Phrase: "The absence of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in parkin-associated parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(4446"

Phrase: ")"

Phrase: "implies"

Phrase: "that"

Phrase: "these inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the primary cause of dopaminergic neuronal degeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0333432:Primary degeneration [Pathologic Function]
   748   C0015127:cause [Functional Concept]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "in parkin-associated parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.227: Parkin consists of three functional domains, the ubiquitin-like, RING1 and RING2 domains (14). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "consists of three functional domains,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205245:Functional [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C0542341:Functional [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "the ubiquitin-like, RING1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419389:RING1 [Gene or Genome]

Phrase: "and"

Phrase: "RING2 domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.228: The RING2 domain was found to be required for binding to ubiquitin-conjugating enzymes (14,17,47) and the ubiquitin-like domain is important for the stability of parkin (16). 

Phrase: "The RING2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1514873:Required [Functional Concept]

Phrase: "to ubiquitin-conjugating enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0084913:Ubiquitin-Conjugating Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0301869:Conjugate [Immunologic Factor]

Phrase: "(14,"

Phrase: "17,"

Phrase: "47"

Phrase: ")"

Phrase: "and"

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "important for the stability of parkin"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.229: However, the RING finger motifs were found later to be essential for parkin binding to its two substrates, CDCrel-1 (17) and Pael-R (47). 

Phrase: "However,"

Phrase: "the RING finger motifs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521759:RING Finger Motifs [Cell Component]
           Ring Finger
   793   C1514562:Motif [Amino Acid Sequence]
   734   C0230398:Finger, ring [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "later to"

Phrase: "be"

Phrase: "essential for parkin binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "to its two substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "Pael-R (47"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0604510:R 47 [Organic Chemical]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.230: Consistent with these findings, we found that sytXI bound to the region between amino acid residues 204 and 293 (Fig.3). 

Phrase: "Consistent with these findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that sytXI"

Phrase: "bound to the region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "between amino acid residues 204"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "293"

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: This region contains the RING1 motif. 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RING1 motif."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.232: Furthermore, a parkin peptide lacking only the ubiquitin-like domain (p78465) bound more weakly to synaptotagmins than parkins containing the ubiquitin-like domain (Fig.3B). 

Phrase: "Furthermore,"

Phrase: "a parkin peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(p78465"

Phrase: ")"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "more weakly to synaptotagmins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0084697:Synaptotagmins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205172:More [Functional Concept]

Phrase: "than parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1418270:PARKIN [Gene or Genome]
   966   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.233: These observations suggest that the ubiquitin-like domain is important for the correct folding of the full-length parkin to expose the RING finger motif for synaptotagmin binding. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "important for the correct folding of the full-length parkin to"

Phrase: "expose"

Phrase: "the RING finger motif for synaptotagmin binding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1521759:Ring Finger Motif [Cell Component]
   748   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.234: We suggest that the three parkin domains serve distinct functions: the ubiquitin-like domain is required for the correct folding and stability of parkin, the p204293 domain, which contains the RING1 finger motif, is essential for the interaction with the C2 domain containing proteins such as sytXI, whereas the RING2 finger motif is important for complex formation with the E1 ubiquitin-activating enzyme and the E2 ubiquitin-conjugate proteins. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the three parkin domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "serve"

Phrase: "distinct functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for the correct folding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0185026:Folding [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]
   760   C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "stability of parkin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205360:Stability [Qualitative Concept]
   790   C2347098:Stability [Qualitative Concept]
   718 E C1547311:Stable [Intellectual Product]

Phrase: "the p204293 domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RING1 finger motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "essential for the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "with the C2 domain containing proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as sytXI,"

Phrase: "whereas"

Phrase: "the RING2 finger motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "important for complex formation"

Phrase: "with the E1 ubiquitin-activating enzyme"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C0163974:Ubiquitin-Activating Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:activating [Activity]
   779 E C1515877:Activate [Functional Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "the E2 ubiquitin-conjugate proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.235: Parkin is an E3 ubiquitin ligase (14,17) that catalyzes the ubiquitination of targeted proteins. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an E3 ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(14,"

Phrase: "17"

Phrase: ")"

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the ubiquitination of targeted proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1519751:Protein Ubiquitination [Molecular Function]
           Ubiquitination
Processing 00000000.tx.236: Polyubiquitination will lead to the degradation of the ubiquitin-conjugated substrate by the proteasome. 

Phrase: "Polyubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514216:Polyubiquitination [Molecular Function]

Phrase: "will"

Phrase: "lead to the degradation of the ubiquitin-conjugated substrate"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243125:degradation [Functional Concept]
   742   C0522529:Conjugated [Spatial Concept]
   742   C0699900:Degradation [Organism Function]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1710236:Substrate [Manufactured Object]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.237: Wild-type parkin strongly catalyzes the polyubiquitination of sytXI compared with truncated parkins, missense mutated parkins, or negative controls (Fig.4). 

Phrase: "Wild-type parkin strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "catalyzes"

Phrase: "the polyubiquitination of sytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514216:Polyubiquitination [Molecular Function]

Phrase: "compared with truncated parkins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1707455:Compared [Activity]
   737   C1418270:PARKIN [Gene or Genome]
   737   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "missense mutated parkins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1418270:PARKIN [Gene or Genome]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "negative controls"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.238: Parkin-dependent ubiquitination also led to rapid turnover of sytXI (Fig.5) further supporting the hypothesis that parkin regulates the level of sytXI. 

Phrase: "Parkin-dependent ubiquitination also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519751:Ubiquitination [Molecular Function]

Phrase: "led to rapid turnover of sytXI"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   753   C0031227:turnover [Quantitative Concept]
   753   C0243127:turnover [Functional Concept]
   753   C0439831:Rapid [Qualitative Concept]
   753   C0443331:Turnover [Health Care Activity]
   753   C1708698:LED [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulates"

Phrase: "the level of sytXI."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.239: Cells expressing truncated parkins or missense mutated parkins (C289G and C418R) produced the same amounts of ubiquitinylated sytXI as cells expressing only GFP-sytXI (Fig.4). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "truncated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "missense mutated parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1418270:PARKIN [Gene or Genome]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C289G"

Phrase: "and"

Phrase: "C418R"

Phrase: ")"

Phrase: "produced"

Phrase: "the same amounts of ubiquitinylated sytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "as cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "only GFP-sytXI"

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.240: These observations suggest that truncating or missense mutations of parkin reduce or eliminate the ubiquitination of sytXI. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that truncating"

Phrase: "or"

Phrase: "missense mutations of parkin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0599155:Mutations, Missense [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reduce"

Phrase: "or"

Phrase: "eliminate"

Phrase: "the ubiquitination of sytXI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.241: In PARK2 AR-JP, mutations of parkin probably cause a decrease in the ubiquitination of specific proteins, resulting in an increase in their intracellular levels of sytXI and other proteins regulated by parkin. 

Phrase: "In PARK2 AR-JP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   888   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   840   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   804   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "mutations of parkin probably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in the ubiquitination of specific proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "resulting in an increase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in their intracellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of sytXI"

Phrase: "and"

Phrase: "other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulated by parkin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.242: The net effect of the abnormal increase in the intracellular levels of parkin-regulated proteins probably contributes to the pathological conditions of AR-JP. 

Phrase: "The net effect of the abnormal increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
   732   C0595938:EFFECT INCREASED [Pathologic Function]

Phrase: "in the intracellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of parkin-regulated proteins probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contributes to the pathological conditions of AR-JP."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   777   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   760   C0441748:Autosomal recessive [Intellectual Product]
   760   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   739   C0030664:Pathological [Biomedical Occupation or Discipline]
   739   C0242422:Parkinsonism [Disease or Syndrome]
   739   C0596142:autosomal [Cell Component]
   739   C1521733:Pathological [Functional Concept]
   739   C1880177:Contribute [Activity]
   739   C3146221:Juvenile [Age Group]
   706   C0012634:condition [Disease or Syndrome]
   706   C0348080:Condition [Qualitative Concept]
   706   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.243: SytXI mRNA is expressed abundantly in the brain, but at lower levels in nonneural tissues (40). 

Phrase: "SytXI mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "expressed"

Phrase: "abundantly in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but at lower levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0441889:Levels [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in nonneural tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.244: However, information on the specific subcellular distribution of endogenous sytXI protein is unknown. 

Phrase: "However,"

Phrase: "information on the specific subcellular distribution of endogenous sytXI protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0021418:Information Distribution [Activity]
   739   C1533716:Information [Idea or Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.245: Exogenous sytXI in PC12 cells was mainly localized in the Golgi network (48). 

Phrase: "Exogenous sytXI in PC12 cells"

Phrase: "was"

Phrase: "mainly"

Phrase: "localized in the Golgi network"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1179875:Golgi network [Cell Component]
   760   C0018042:Golgi [Cell Component]
   760   C0392752:Localized [Spatial Concept]
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.246: In non-transfected NGF-induced PC12 cells, endogenous parkin and sytXI were found co-localized in a perinuclear distribution and in dense-core vesicles in the NGF-induced processes (Fig.6). 

Phrase: "In non-transfected NGF-induced PC12 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0085262:PC12 Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "endogenous parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sytXI"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "co-localized in a perinuclear distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392752:Localized [Spatial Concept]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and in dense-core vesicles"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0887944:Dense Core Vesicles [Cell Component]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C0439794:Dense [Qualitative Concept]
   760   C0444669:Core [Spatial Concept]
   760   C1167518:core [Cell Component]
   760   C1515981:And [Idea or Concept]
   760   C1706352:Core [Medical Device]
   760   C1882467:Core [Manufactured Object]
   760   C3274653:Core [Body Substance]
   726 E C1622418:vesicle [Cell Component]

Phrase: "in the NGF-induced processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.247: The distribution pattern of endogenous parkin was similar to previous observations (33). 

Phrase: "The distribution pattern of endogenous parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "similar to previous observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.248: The distribution of sytXI was also similar to the subcellular distribution of sytIV, a protein with 48% identity to sytXI. 

Phrase: "The distribution of sytXI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "also similar to the subcellular distribution of sytIV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "a protein with 48% identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to sytXI."
Processing 00000000.tx.249: In PC12 cells, sytIV is localized mainly in the Golgi and immature vesicles (4952). 

Phrase: "In PC12 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "sytIV"

Phrase: "is"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "mainly in the Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018042:Golgi [Cell Component]

Phrase: "and"

Phrase: "immature vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(4952"

Phrase: ")."
Processing 00000000.tx.250: When PC12 cells are treated with NGF, sytIV protein redistributes to the mature dense-core vesicles (52). 

Phrase: "When"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "treated with NGF,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1417719:NGF [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "sytIV protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286878:SytIV Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "redistributes to the mature dense-core vesicles"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0887944:Dense Core Vesicles [Cell Component]
   748   C0205286:Mature [Temporal Concept]
   748   C0333262:VESICLES [Acquired Abnormality]
   748   C0439794:Dense [Qualitative Concept]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]
   714 E C1622418:vesicle [Cell Component]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.251: Dense-core vesicles are secretory granules that carry neuropeptides or biogenic amines, and release their contents under the stimulation of calcium ions. 

Phrase: "Dense-core vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887944:Dense Core Vesicles [Cell Component]
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "are"

Phrase: "secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "that"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "biogenic amines,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005496:Biogenic Amines [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0002508:Amines [Organic Chemical]
   827 E C1879694:Amine [Organic Chemical]

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "their contents under the stimulation of calcium ions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456205:Contents [Conceptual Entity]
   744   C1552853:contents [Idea or Concept]
   711 E C0423896:Content [Mental Process]
Processing 00000000.tx.252: Therefore, the observation that both sytXI and parkin co-localize in the dense-core vesicles suggests that both proteins probably play a role in the calcium-dependent exocytosis. 

Phrase: "Therefore,"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "both sytXI"

Phrase: "and"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-localize in the dense-core vesicles"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0887944:Dense Core Vesicles [Cell Component]
   748   C0333262:VESICLES [Acquired Abnormality]
   748   C0392752:localize [Spatial Concept]
   748   C0439794:Dense [Qualitative Concept]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]
   714 E C1622418:vesicle [Cell Component]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both proteins probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the calcium-dependent exocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.253: This hypothesis is further supported by the observation that both parkin and sytXI have similar distribution patterns in the neurites and cell bodies of neurons in the human substantia nigra (Fig.6). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "both parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sytXI"

Phrase: "have"

Phrase: "similar distribution patterns in the neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:distribution patterns [Spatial Concept]
   753   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "cell bodies of neurons"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   977   C0599444:Cell body of neuron [Cell Component]
           neuron cell body
           bodies cell
   799 E C2752549:cell body [Cell Component]
   786   C0682679:neuron body [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0242821:bodies [Human]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "in the human substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   901   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.254: One can speculate that the loss of parkin function in patients with AR-JP alters synaptotagmin XI function resulting in altered dopamine release, which in turn causes the symptoms of dystonia and parkinsonism. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "can"

Phrase: "speculate"

Phrase: "that"

Phrase: "the loss of parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "synaptotagmin XI function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1426106:synaptotagmin XI [Gene or Genome]

Phrase: "resulting in altered dopamine release,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0332294:Resulting in [Functional Concept]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0392747:Altered [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the symptoms of dystonia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683368:symptoms [Functional Concept]
   770   C1457887:Symptoms [Sign or Symptom]

Phrase: "and"

Phrase: "parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.255: Altered vesicle functioning, be it at the stages of release or recycling, may cause an increase of cytoplasmic dopamine resulting in increased oxidative damage, and subsequently in cell death explaining the neurodegeneration seen in patients with parkin mutations.  

Phrase: "Altered vesicle functioning,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0542341:functioning [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]

Phrase: "be"

Phrase: "it at the stages of release"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1306673:Stages [Qualitative Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]

Phrase: "or"

Phrase: "recycling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase of cytoplasmic dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "resulting in increased oxidative damage,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   760   C0010957:Damage [Injury or Poisoning]
   760   C0205217:Increased [Quantitative Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1883709:Damage [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "subsequently in cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007587:Cell Death [Cell Function]
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "explaining"

Phrase: "the neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "seen in patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "with parkin mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.256: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Plasmid constructs To prepare the yeast two-hybrid bait plasmid pGBT9-parkin (1465), we excised the full-length parkin cDNA encoding amino acids 1465 from pEGFPC1-parkin [previously described in Huynh et al. (33)] and ligated it into the pGBT9 plasmid (Clontech). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "the yeast two-hybrid bait plasmid pGBT9-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1418270:PARKIN [Gene or Genome]
   795   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1465"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "excised"

Phrase: "the full-length parkin cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 1465 from pEGFPC1-parkin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "[previously"

Phrase: "described in Huynh et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "ligated"

Phrase: "it into the pGBT9 plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.257: The full-length cDNAs of human sytI and sytXI were obtained by PCR from a human adult brain cDNA library cloned in the pGAD10 expression plasmid (Clontech) using primer pairs spanning the entire reading frame. 

Phrase: "The full-length cDNAs of human sytI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "sytXI"

Phrase: "were"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from a human adult brain cDNA library"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "cloned in the pGAD10 expression plasmid"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0009013:cloned [Cell]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   719 E C1522642:Clone [Tissue]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the entire reading frame."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0180979:Frame [Medical Device]
   827   C1705179:Reading [Finding]
   827   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.258: All others expression plasmids were similarly constructed using specific PCR primer pairs. 

Phrase: "All others expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "similarly"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific PCR primer pairs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.259: The mutant parkin cDNAs, parkinG289G and parkinC418R, were gifts from Professor Alexis Brice of INSERM U289, Hpital de la Salpetrire, Paris, France. 

Phrase: "The mutant parkin cDNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "parkinG289G"

Phrase: "and"

Phrase: "parkinC418R,"

Phrase: "were"

Phrase: "gifts from Professor Alexis Brice of INSERM U289,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0445425:alexis [Intellectual Product]
   744   C0599518:Professor [Professional or Occupational Group]
   744   C1136188:Gifts [Entity]

Phrase: "Hpital de la Salpetrire,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.260: Identification of parkin interacting proteins A yeast two-hybrid screen of a human adult brain cDNA library cloned in the GAL4 activation domain vector pGAD10 was performed using as the bait pGBT9-parkin (1465), encoding parkin amino acids 1465 fused to the GAL4 binding domain (vectors and library from Clontech). 

Phrase: "Identification of parkin interacting proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "A yeast two-hybrid screen of a human adult brain cDNA library"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0599647:Two Hybrid [Molecular Biology Research Technique]
   736   C0020205:Hybrid [Organism]
   736   C0036025:yeast [Fungus]
   736   C0043392:Yeast [Food]
   736   C0043393:Yeast [Fungus]
   736   C0205448:Two [Quantitative Concept]
   736   C0220908:screen [Health Care Activity]
   736   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   736   C1305399:screen [Functional Concept]
   736   C1705053:Screen [Medical Device]

Phrase: "cloned in the GAL4 activation domain vector pGAD10"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0009013:cloned [Cell]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vector [Spatial Concept]
   744   C1416832:GAL4 [Gene or Genome]
   744   C1705099:Vector [Idea or Concept]
   744   C1879547:Activation [Activity]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711 E C1522642:Clone [Tissue]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using as the bait pGBT9-parkin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C1418270:PARKIN [Gene or Genome]
   753   C1524063:Using [Functional Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(1465"

Phrase: ")"

Phrase: ","

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "parkin amino acids 1465"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "fused to the GAL4 binding domain"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0243122:binding [Functional Concept]
   753   C0699952:Fused [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "(vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "library from Clontech"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0023621:Library [Manufactured Object,Organization]
   790   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.261: As previously described (53,54), the bait plasmid was co-transformed in yeast strain Y190 and grown on synthetic media without leucine, tryptophan and histidine, and with 25mM 3-amino-1,2,4-triazole and 2% glucose. 

Phrase: "As"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: ","

Phrase: "the bait plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "co-transformed in yeast strain Y190"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1510411:Transformed [Pathologic Function]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "grown on synthetic media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1883254:synthetic [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "without leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "histidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and with 25mM 3-amino-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515981:And [Idea or Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-triazole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040880:Triazole [Organic Chemical]

Phrase: "and"

Phrase: "2% glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.262: The Y190 strain allows for nutritional selection of the HIS3 gene that allows growth in media lacking histidine, and color selection using the LacZ gene encoding -galactosidase. 

Phrase: "The Y190 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "allows for nutritional selection of the HIS3 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0017337:Gene [Gene or Genome]
   744   C0036576:selection [Genetic Function]
   744   C0683607:allow [Social Behavior]
   744   C1521739:Nutritional [Qualitative Concept]
   744   C2707262:Nutritional [Clinical Attribute]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "growth in media"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "histidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "color selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the LacZ gene encoding -galactosidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.263: The -galactosidase reporter was assayed on stamped nitrocellulose filters by incubating freeze-fractured colonies in Z-buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, pH 7.0, 0.03mM -mercaptoethanol, and 2.5M X-gal) at 37C for 15min to 8h. 

Phrase: "The -galactosidase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0335038:Reporter [Professional or Occupational Group]
   861   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   861   C1705915:Reporter [Conceptual Entity]
   861   C1709908:Reporter [Group]

Phrase: "was"

Phrase: "assayed on stamped nitrocellulose filters"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0180860:Filters [Manufactured Object]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726 E C0581406:Filter [Medical Device]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1522664:Filter [Intellectual Product]
   726 E C1704449:Filter [Conceptual Entity]
   726 E C1704684:Filter [Medical Device]
   726   C1823540:STAMP [Gene or Genome]
   726 E C1875155:FILTER [Medical Device]

Phrase: "by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "freeze-fractured"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0016700:freeze fracture [Laboratory Procedure]
   861   C0016658:Fractured [Injury or Poisoning]
   861   C0016701:Freeze [Natural Phenomenon or Process]

Phrase: "colonies in Z-buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439158:colonies [Quantitative Concept]
   737 E C1947989:Colony [Cell]

Phrase: "(60mM Na2HPO4,"

Phrase: "40mM NaH2PO4,"

Phrase: "10mM KCl,"

Phrase: "1mM MgSO4,"

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.03mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "2.5M X-gal) at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0049081:X-gal [Carbohydrate]

Phrase: "for 15min"

Phrase: "to 8h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292429:8H [Temporal Concept]
Processing 00000000.tx.264: Positive clones were restreaked on synthetic media without leucine or tryptophan, and retested for -galactosidase activity, and then pGAD10 prey plasmids were isolated. 

Phrase: "Positive clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "restreaked on synthetic media"

Phrase: "without leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "tryptophan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "retested for -galactosidase activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1150051:galactosidase activity [Molecular Function]
   770   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C1698057:retest [Idea or Concept]

Phrase: "and"

Phrase: "then pGAD10 prey plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "isolated."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.265: A pGAD10 plasmid containing a partial sequence encoding the human synaptotagmin XI gene was purified and then retransformed with pGBT9-parkin (1465) or negative control plasmids (pGBT9 vector, pGBT9-NF2, pGBT9-HRS) and retested for -galactosidase activity. 

Phrase: "A pGAD10 plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a partial sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the human synaptotagmin XI gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0314604:Human gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "retransformed with pGBT9-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1465"

Phrase: ")"

Phrase: "or"

Phrase: "negative control plasmids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1639518:% negative control [Quantitative Concept]
   734   C1947986:Negative Control [Conceptual Entity]

Phrase: "(pGBT9 vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "pGBT9-NF2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0027832:Neurofibromatosis 2 [Neoplastic Process]
   827   C0027831:Neurofibromatosis [Neoplastic Process]
   827   C0085113:neurofibromatosis [Gene or Genome]
   827   C0162678:Neurofibromatosis [Neoplastic Process]
   827   C3540584:Neurofibromatosis [Intellectual Product]

Phrase: "pGBT9-HRS"

Phrase: ")"

Phrase: "and"

Phrase: "retested for -galactosidase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1150051:galactosidase activity [Molecular Function]
   770   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C1698057:retest [Idea or Concept]
Processing 00000000.tx.266: To obtain semi-quantitative estimates of interaction strengths between various parkin and synaptotagmin XI protein fragments, liquid assays for -galactosidase were conducted by incubating Y190 yeast cells extracted in Z-buffer and 5% chloroform with 0.6mg/ml o-nitrophenylgalactoside for 2min to 1h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "semi-quantitative estimates of interaction strengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750572:estimates [Quantitative Concept]

Phrase: "between various parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "synaptotagmin XI protein fragments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "liquid assays for -galactosidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "conducted by incubating Y190 yeast cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C2700289:Yeast Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1439852:incubating [Laboratory Procedure]
   753   C3282337:Cells [Cell]
   719   C0004927:Conduct [Individual Behavior]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "extracted in Z-buffer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "5% chloroform with 0.6mg/ml o-nitrophenylgalactoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for 2min"

Phrase: "to 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.267: Standard deviations were calculated from triplicate measures of replicate cultures. 

Phrase: "Standard deviations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0871420:Standard deviation [Quantitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827   C0012727:Deviation [Spatial Concept]
   827   C0205419:Deviation [Qualitative Concept]
   827   C1705236:Deviation [Finding]

Phrase: "were"

Phrase: "calculated from triplicate measures of replicate cultures."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C0010453:Cultures [Idea or Concept]
   748   C0079809:Measures [Quantitative Concept]
   748   C0205173:Replicate [Functional Concept]
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0205341:Replicate [Functional Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1879489:Measures [Functional Concept]
   748   C1883725:Replicate [Qualitative Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.268: -Galactosidase activity was expressed as Miller units (Miller unit=1000x[OD420/(OD600xtimexvolume)] (55). 

Phrase: "-Galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150051:galactosidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "expressed as Miller units"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0402830:Miller [Professional or Occupational Group]
   770   C0439148:Units [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "(Miller unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "=1000x"

Phrase: "[OD420/"

Phrase: "(OD600xtimexvolume"

Phrase: ")"

Phrase: "]"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.269: In vitro co-immunoprecipitation To perform the co-ip, we first co-transfected HA-tagged parkin expression cDNAs (pCMVHAparkin, pCMVHAtruncated parkins, pCMVHAparkinC418R, pCMVHAparkinG289R) with the respective GFP tagged fusion protein expression vectors (pEGFPhsytXIAB, pEGFPsytI, pEGFP-sytXI, or pEGFP) into HEK293 cells growing at 6080% confluency in 100mm2 dishes. 

Phrase: "In vitro co-immunoprecipitation To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   804   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the"

Phrase: "co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "co-transfected"

Phrase: "HA-tagged parkin expression cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(pCMVHAparkin,"

Phrase: "pCMVHAtruncated parkins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "pCMVHAparkinC418R,"

Phrase: "pCMVHAparkinG289R"

Phrase: ")"

Phrase: "with the respective GFP tagged fusion protein expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   818   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0442335:Vectors [Spatial Concept]
   762 E C1705099:Vector [Idea or Concept]

Phrase: "(pEGFPhsytXIAB,"

Phrase: "pEGFPsytI,"

Phrase: "pEGFP-sytXI,"

Phrase: "or"

Phrase: "pEGFP) into HEK293 cells"

Phrase: "growing at 6080% confluency"

Phrase: "in 100mm2 dishes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.270: Controls were cells transfected only with the pCMVHAparkin or non-transfected cells. 

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected"

Phrase: "only with the pCMVHAparkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "or"

Phrase: "non-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.271: After 48h, proteins were extracted with detergent buffer containing 0.5% NP40 and protease inhibitor mixture (Roche). 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "extracted with detergent buffer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0011740:Detergent [Chemical Viewed Functionally]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% NP40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.272: Protein extracts were immunoprecipitated (ip) with anti-GFP (Chemicon), or rat anti-HA agarose matrix (Roche). 

Phrase: "Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated (ip) with anti-GFP (Chemicon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "or rat anti-HA agarose matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704640:Matrix [Spatial Concept]
   799   C1706515:Matrix [Body Substance]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.273: IP products were immunoblotted with anti-GFP antibody and anti-HA conjugated peroxidase. 

Phrase: "IP products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "immunoblotted with anti-GFP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "and"

Phrase: "anti-HA"

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "peroxidase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.274: Co-immunoprecipitation of human brain extracts A 1.4g sample of human cerebral cortex was chopped into small pieces and resuspended in 7ml of cold lysis buffer (100mM TrisHCl, pH 7.5, 150mM NaCl, 1% Triton X-100, 0.05% SDS, 0.05% deoxycholic acid, and 1 protease inhibitor pellet/10ml buffer). 

Phrase: "Co-immunoprecipitation of human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "A 1.4g sample of human cerebral cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "chopped into small pieces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0700321:Small [Quantitative Concept]
   737   C2945739:chop [Activity]
   737   C2982836:Piece [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in 7ml of cold lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0024348:Lysis [Pathologic Function]
   748   C0234192:Cold [Physiologic Function]
   748   C1536403:lysis [Cell Function]

Phrase: "(100mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "0.05% SDS,"

Phrase: "0.05% deoxycholic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011479:Deoxycholic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "1 protease inhibitor pellet/10ml buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.275: The cell suspension was homogenized by a glass homogenizer. 

Phrase: "The cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "homogenized by a glass homogenizer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017596:Glass [Manufactured Object]
   760   C0181200:homogenizer [Medical Device]
   760   C1947936:Glass [Medical Device]
Processing 00000000.tx.276: Protein lysate was aliquoted into 1ml aliquots and microfuged at top speed in the cold room. 

Phrase: "Protein lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "aliquoted into 1ml aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "and"

Phrase: "microfuged at top speed"

Phrase: "in the cold room."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.277: Protein extracts were precleared with rabbit IgG conjugated agarose and protein A conjugated agarose for 3h at 4C, and the precleared lysate was incubated with rabbit anti-parkA or mouse anti-sytXI antibody overnight in the cold room. 

Phrase: "Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "precleared with rabbit IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034493:Rabbit [Mammal]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036681:Agarose [Carbohydrate]

Phrase: "and"

Phrase: "protein A conjugated agarose for 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036681:Agarose [Carbohydrate]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "the precleared lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "incubated with rabbit anti-parkA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034493:Rabbit [Mammal]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "mouse anti-sytXI antibody overnight in the cold room."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0056097:Cold antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.278: The primary antibodies were pulled down with protein A conjugated agarose for 4h at 4C. 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "pulled down"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0580846:pulled [Finding]

Phrase: "with protein A conjugated agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.279: The final pellets were washed five times with co-ip buffer, and the coprecipitates were eluted from the secondary antibody-conjugated agarose with SDSPAGE buffer. 

Phrase: "The final pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:times [Temporal Concept]
   790   C1632851:Times [Quantitative Concept]
   756 E C3541383:Time [Temporal Concept]
   718 E C0442043:Temporal [Spatial Concept]
   718 E C2362314:Temporal [Temporal Concept]

Phrase: "co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "the"

Phrase: "coprecipitates"

Phrase: "were"

Phrase: "eluted from the secondary antibody-conjugated agarose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0036681:Agarose [Carbohydrate]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0522529:Conjugated [Spatial Concept]

Phrase: "with SDSPAGE buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.280: Co-ip products were immunoblotted with either chick anti-parkA or anti-sytXIA antibody. 

Phrase: "Co-ip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "immunoblotted with either chick anti-parkA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "or"

Phrase: "anti-sytXIA antibody."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.281: Ubiquitination and degradation assays HEK293 cells were transfected with 5g of pCMVMycUbiquitin, pEGFPsytI or SytXI, and different pCMV-HA-parkins (wild-type, truncated, and missense). 

Phrase: "Ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation assays HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2936239:HEK293 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 5g of pCMVMycUbiquitin,"

Phrase: "pEGFPsytI"

Phrase: "or"

Phrase: "SytXI,"

Phrase: "and"

Phrase: "different pCMV-HA-parkins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1418270:PARKIN [Gene or Genome]
   779   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(wild-type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "truncated"

Phrase: ","

Phrase: "and"

Phrase: "missense"

Phrase: ")."
Processing 00000000.tx.282: After 24h, cells were incubated in normal media containing 20M lactacystin or 20M proteasome inhibitor I for 4h. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in normal media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1254021:Media [Tissue]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20M lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "20M proteasome inhibitor I for 4h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1674020:proteasome inhibitor I [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.283: Cells were washed with cold DPBS, and proteins were extracted with RIPA buffer containing protease inhibitor pellet (Roche, 1 pellet per 10ml buffer), and 2M N-ethylamimide to inhibit deubiquitination enzymes. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with cold DPBS,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0234192:Cold [Physiologic Function]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "extracted with RIPA buffer containing protease inhibitor pellet"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   770   C3536890:Protease Inhibitor [Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0034584:RIPA [Laboratory Procedure]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0332256:Containing [Functional Concept]
   744   C0441436:Pellet [Manufactured Object]
   744   C0993610:Pellet [Biomedical or Dental Material]
   744   C1947941:Protease [Enzyme]
   744   C1998480:Pellet [Quantitative Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   744   C2700400:Containing [Activity]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]

Phrase: "(Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "1 pellet per 10ml buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1998480:Pellet [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "2M N-ethylamimide to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "deubiquitination enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.284: Protein extracts were immunoprecipitated with mouse antiGFP antibody, and the IP products were detected with anti-HA, anti-myc, and rabbit anti-GFP. 

Phrase: "Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with mouse antiGFP antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the IP products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "detected with anti-HA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "anti-myc,"

Phrase: "and"

Phrase: "rabbit anti-GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.285: To determine whether parkin accelerates GFP-sytXI degradation, HEK293 cells were co-transfected with GFP-sytXI and HA-vector or GFP-sytXI and HA-parkin plasmids. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "GFP-sytXI degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with GFP-sytXI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "HA-vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "or"

Phrase: "GFP-sytXI"

Phrase: "and"

Phrase: "HA-parkin plasmids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.286: After 24h, cells were washed once with DMEM containing 5% dialyzed FBS and no Met and Cys amino acids. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with DMEM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% dialyzed FBS"

Phrase: "and"

Phrase: "no Met"

Phrase: "and"

Phrase: "Cys amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.287: Cells were incubated in this media for 30min, and grown in the same media containing 100Ci/ml of 35S-Met/Cys (EXPRE35S35S [35S]Protein Labeling Mix, Amersham) for 30min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in this media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "for 30min,"

Phrase: "and"

Phrase: "grown in the same media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0445247:Same [Qualitative Concept]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100Ci/ml of 35S-Met/Cys (EXPRE35S35S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439526:/mL [Quantitative Concept]

Phrase: "[35S"

Phrase: "]Protein Labeling Mix,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205430:Mix [Functional Concept]
   827   C1421951:MIX [Gene or Genome]
   827   C1720722:Mix [Qualitative Concept]

Phrase: "Amersham"

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.288: Cells were then chased at the indicated time points. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "chased at the indicated time points."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]
Processing 00000000.tx.289: Protein extracts were isolated using RIPA buffer (20mM HEPES, pH 7.5, 150mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% Triton-X100, 1mM EDTA, protease mixture pellet). 

Phrase: "Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RIPA buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% SDS,"

Phrase: "0.5% deoxycholate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "1% Triton-X100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0146951:Triton X100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "protease mixture pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441436:Pellet [Manufactured Object]
   827   C0993610:Pellet [Biomedical or Dental Material]
   827   C1998480:Pellet [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.290: GFP-sytXI was immunoprecipitated with rabbit anti-GFP antibody (CHEMICON) as described above. 

Phrase: "GFP-sytXI"

Phrase: "was"

Phrase: "immunoprecipitated with rabbit anti-GFP antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(CHEMICON"

Phrase: ")"

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.291: Antibodies Mouse monoclonal antibody to syt65 (Stressgen, -actin (Sigma), -COP (Sigma), and rabbit ubiquitin antibody (DAKO) were purchased. 

Phrase: "Antibodies Mouse monoclonal antibody to syt65"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Monoclonal Antibodies
   753   C0746619:monoclonal [Finding]

Phrase: "(Stressgen, -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ", -"

Phrase: "COP (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rabbit ubiquitin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(DAKO"

Phrase: ")"

Phrase: "were"

Phrase: "purchased."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0869011:purchased [Activity]
Processing 00000000.tx.292: The following reagents were purchased from Roche Diagnostic: mouse anti-HA, anti-HA-peroxidase, anti-myc-peroxidase, anti-HA-agarose. 

Phrase: "The following reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Roche"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0331965:Roche [Health Care Related Organization]
   790   C0869011:purchased [Activity]

Phrase: "Diagnostic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011900:Diagnostic [Finding]
  1000   C0348026:Diagnostic [Functional Concept]

Phrase: ":"

Phrase: "mouse anti-HA,"

Phrase: "anti-HA-peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-myc-peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-HA-agarose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]
Processing 00000000.tx.293: The rabbit anti-sytXIA antibody was made against the sytXIA peptide (HQQAEKKQKNPPYKF) by QCP. 

Phrase: "The rabbit anti-sytXIA antibody"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "made against the sytXIA peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   726   C1881534:Make [Functional Concept]

Phrase: "(HQQAEKKQKNPPYKF"

Phrase: ")"

Phrase: "by QCP."
Processing 00000000.tx.294: Another antibody against the sytXIB peptide (KVRRDKDGPRRESGRG) was made, but this antibody recognized multiple bands in western blots of human and PC12 cells protein extracts (data not shown). 

Phrase: "Another antibody against the sytXIB peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(KVRRDKDGPRRESGRG"

Phrase: ")"

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "this antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "multiple bands in western blots of human"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0175723:Bands [Medical Device]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "PC12 cells protein extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0007592:Cell Extracts [Cell Component]
   779   C2828366:Extract [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.295: The anti-sytXIA antibody was affinity purified by a sepharose-sytXIA column. 

Phrase: "The anti-sytXIA antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified by a sepharose-sytXIA column."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036681:Sepharose [Carbohydrate]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.296: The rabbit and chicken antiparkA was made against peptide ParkA as described in detail in Huynh et al. 

Phrase: "The rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "and"

Phrase: "chicken antiparkA"

Phrase: "was"

Phrase: "made against peptide ParkA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   737   C1881534:Make [Functional Concept]

Phrase: "as"

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "in Huynh et al."
Processing 00000000.tx.297: (33). 

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.298: Cell cultures COS1 cells were grown in DMEM medium supplemented with 10% FBS and penicillin/streptomycin, in 37C incubator with 5% CO2. 

Phrase: "Cell cultures COS1 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "grown in DMEM medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "penicillin/streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "in 37C incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]

Phrase: "with 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.299: Media were changed every 3 days. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "every 3 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.300: One day prior to transfection, 50000 cells were seeded in a 1cm coverslip previously coated with 20g/ml collagen IV. 

Phrase: "One day prior to transfection,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]

Phrase: "50000 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in a 1cm coverslip previously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "coated with 20g/ml collagen IV."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0009333:Collagen IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0238286:ML IV [Disease or Syndrome]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0439526:/mL [Quantitative Concept]
   753   C1167364:collagen [Cell Component]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.301: For PC12 cells, cells were grown in DMEM containing 10% heat-inactivated serum, 5% fetal bovine serum, and penicillin/streptomycin in a 37C incubator with 10% CO2. 

Phrase: "For PC12 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% heat-inactivated serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "5% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "penicillin/streptomycin in a 37C incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "with 10% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.302: Media were changed every 3 days. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "every 3 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.303: Immunohistochemical labeling of human substantia nigra sections Human brain 7m sections were stained with rabbit anti-sytXIA (10g/ml), parkA (5g/ml), ubiquitin (1/500) antibodies using the immunohistochemical labeling protocols described in Huynh et al. 

Phrase: "Immunohistochemical labeling of human substantia nigra sections Human brain 7m sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1167624:Labeling [Mental Process]
   738   C1947902:Labeling [Manufactured Object]
   738   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "stained with rabbit anti-sytXIA"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0034493:Rabbit [Mammal]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "parkA"

Phrase: "(5g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the immunohistochemical labeling protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]

Phrase: "described in Huynh et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.304: (33). 

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.305: Briefly, brains sections were deparafinized and demasked by Biomedia's Autozyme solution (Fisher). 

Phrase: "Briefly,"

Phrase: "brains sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "deparafinized"

Phrase: "and"

Phrase: "demasked by Biomedia's Autozyme solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: ")."
Processing 00000000.tx.306: Sections were then blocked with 3% normal goat serum, and incubated with the primary antibody overnight in the cold room. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "blocked with 3% normal goat serum,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   753   C0018019:goat [Mammal]
   753   C0028778:Blocked [Pathologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1265549:goat [Mammal]
   753   C1510458:Goat [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with the primary antibody overnight"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the cold room."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.307: Next day, sections were developed using the Elite Vector ABC kit (Vector, San Diego, CA, USA), and the Biomedia's diaminobenzidene substrate kit (Fisher). 

Phrase: "Next day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Elite Vector ABC kit (Vector,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Biomedia's diaminobenzidene substrate kit (Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0325045:Fisher [Mammal]

Phrase: ")."
Processing 00000000.tx.308: For peptide preabsorption, 10g of anti-sytXIA antibody were preincubated with 1000-fold sytXIA peptide overnight in the cold room. 

Phrase: "For peptide preabsorption,"

Phrase: "10g of anti-sytXIA antibody"

Phrase: "were"

Phrase: "preincubated with 1000-fold sytXIA peptide overnight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332462:Fold [Spatial Concept]
   748   C0439583:Overnight [Temporal Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "in the cold room."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.309: The next day, the preincubated antibody was microfuged for 10min, and diluted in 1ml of the staining buffer. 

Phrase: "The next day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the preincubated antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "microfuged for 10min,"

Phrase: "and"

Phrase: "diluted in 1ml of the staining buffer."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]
Processing 00000000.tx.310: Images were acquired using the 20x and 63x oil immersion lenses, and captured by a SPOT digital camera. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 20x"

Phrase: "and"

Phrase: "63x oil immersion lenses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0023318:Lenses [Medical Device]
   779 E C0023317:Lens [Body Part, Organ, or Organ Component]
   779 E C0996842:Lens [Plant]
   779 E C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "captured by a SPOT digital camera."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0179533:Camera [Medical Device]
   753   C0329155:Spot [Fish]
   753   C0442015:Digital [Intellectual Product]
   753   C1427618:SPOT [Gene or Genome]
   753   C1654607:Camera [Eukaryote]
   753   C1705203:Spot [Conceptual Entity]
   753   C1706254:CAMERA [Medical Device]
   753   C1883674:Digital [Qualitative Concept]
Processing 00000000.tx.311: Transfection methods Cells were plated 24h prior to transfection. 

Phrase: "Transfection methods Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "24h prior to transfection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456696:/24h [Temporal Concept]
   770   C1442770:24H [Temporal Concept]
Processing 00000000.tx.312: On the following day, cDNA plasmids were treated with polyfect transfectant reagent (Qiagen) and transfected into HEK293 cells according to the manufacturer's protocol. 

Phrase: "On the following day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "cDNA plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "treated with polyfect transfectant reagent"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "and"

Phrase: "transfected into HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.313: At desired time point (24, 48, and 72h) after transfection, cells were fixed for immunofluorescence labeling, or extracted for immunoprecipitation and western blots. 

Phrase: "At desired time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "(24,"

Phrase: "48,"

Phrase: "and"

Phrase: "72h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292423:72H [Temporal Concept]

Phrase: ")"

Phrase: "after"

Phrase: "transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed for immunofluorescence labeling,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827483:Fixed [Body Substance]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "or"

Phrase: "extracted for immunoprecipitation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "western blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.314: For cells that were examined longer than 24h after transfection, the media were changed once. 

Phrase: "For cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "longer than 24h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0205166:Long [Qualitative Concept]
   756   C1706317:Long [Qualitative Concept]
   706 E C1444754:Length [Quantitative Concept]
   706 E C1706316:LENGTH [Research Activity]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "once."
Processing 00000000.tx.315: Immunofluorescent labeling and confocal laser microscopy Cells were fixed with 4% paraformaldehyde in DPBS for 20min on ice, and incubated in solution A (DPBS, 3% goat serum, 0.05% Triton X-100) for 30min. 

Phrase: "Immunofluorescent labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "confocal laser microscopy Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C0242842:Microscopy, Confocal [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in DPBS"

Phrase: "for 20min"

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in solution A (DPBS,"

Phrase: "3% goat serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "0.05% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.316: Cells were then incubated with selected mouse or rabbit primary antibody diluted in solution A for 1h at room temperature. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with selected mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1439852:Incubated [Laboratory Procedure]
   737   C1707391:Select [Activity]

Phrase: "or"

Phrase: "rabbit primary antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "in solution A for 1h"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.317: Cells were then washed five times with cold DPBS, and incubated with the corresponding secondary antibody conjugated to either FITC or TRITC diluted in solution A for 1h at room temperature. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with cold DPBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "incubated with the corresponding secondary antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "conjugated to either FITC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0522529:Conjugated [Spatial Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "or"

Phrase: "TRITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "in solution A for 1h"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.318: Cells were then again washed five times with cold DPBS and covered with a slide in 80% glycerol and 10mM sodium gallate for fading protection. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then again"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with cold DPBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "covered with a slide"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439844:Covered [Functional Concept]
   770   C0444330:Slide [Research Device]
   770   C1705201:Slide [Manufactured Object]
   770   C1999244:Covered [Functional Concept]
   737 E C0180153:cover [Medical Device]
   737 E C1707529:Cover [Medical Device]

Phrase: "in 80% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10mM sodium gallate for fading protection."
Processing 00000000.tx.319: Cells were viewed with a Leica TCSSP (true confocal scanner spectrophotometry) microscope through the oil immersion 100x lens. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "viewed with a Leica TCSSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0449911:View [Spatial Concept]

Phrase: "(true confocal scanner spectrophotometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037805:Spectrophotometry [Laboratory Procedure]

Phrase: ")"

Phrase: "microscope through the oil immersion 100x lens."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0181839:Microscope [Medical Device]
   748   C1706379:Microscope [Medical Device]
Processing 00000000.tx.320: Images were acquired sequentially to prevent bleaching between FITC and GFP with TRITC fluorescence. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "sequentially to"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "bleaching between FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "and"

Phrase: "GFP with TRITC fluorescence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.321: Protein extraction and western blots At predetermined time point after transfection, cells were extracted with weak detergent CO-IP buffer (20mM Hepes, pH 7.2, 150mM NaCl, 0.5% Triton X100). 

Phrase: "Protein extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "western blots At predetermined time point"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1705493:Western [Spatial Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "extracted with weak detergent CO-IP buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0004093:Weak [Sign or Symptom]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0011740:Detergent [Chemical Viewed Functionally]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C1762617:Weak [Qualitative Concept]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "(20mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.5% Triton X100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0146951:Triton X100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.322: For ubiquitination assays and antibody analysis, cells or tissues were extracted with strong triple detergent buffer (20mM Hepes, pH 7.2, 150mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate). 

Phrase: "For ubiquitination assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "antibody analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "extracted with strong triple detergent buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205174:Triple [Quantitative Concept]
   753   C0442821:Strong [Qualitative Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "(20mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "0.1% SDS,"

Phrase: "0.5% deoxycholate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.323: The protein extracts were clarified by 30min centrifugation using a tabletop Beckmann Microfuge. 

Phrase: "The protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "clarified by 30min centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C2986669:Clarified [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a tabletop Beckmann Microfuge."
Processing 00000000.tx.324: For western blot, 10l of the protein extract was loaded per well of a 15-well 420% gradient, mini SDSpolyacrylamide gel. 

Phrase: "For western blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "10l of the protein extract"

Phrase: "was"

Phrase: "loaded per well of a 15-well 420% gradient,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0205170:Well [Qualitative Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1708715:Loaded [Activity]
   742   C3146287:Well [Manufactured Object]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "mini SDSpolyacrylamide gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.325: Proteins were resolved at 100V for 2h and transferred to Amersham's nitrocellulose filter overnight at 30V in the cold room. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved at 100V"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514893:Resolved [Idea or Concept]
   790   C2699488:Resolved [Conceptual Entity]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "and"

Phrase: "transferred to Amersham's nitrocellulose"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0348011:transferred [Functional Concept]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "filter"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "overnight at 30V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "in the cold room."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.326: The filter was then removed from the western blot apparatus, and blocked with 5% non-fat milk for 1h at room temperature. 

Phrase: "The filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed from the western blot apparatus,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C0243111:apparatus [Manufactured Object]
   753   C0849355:Removed [Qualitative Concept]
   753   C1705493:Western [Spatial Concept]
   753   C1947951:Apparatus [Anatomical Structure]
   719 E C1883720:Remove [Activity]
   719 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "blocked with 5% non-fat milk"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0991850:fat milk [Lipid,Pharmacologic Substance]
   753   C0026131:Milk [Body Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C0349374:Milk [Food]
   753   C0424612:FAT [Organism Attribute]
   753   C0444318:Milk [Substance]
   753   C1518422:Non [Functional Concept]
   753   C2825079:Milk [Food]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.327: The blocking solution was then replaced with blocking solution containing the desired concentration of primary antibody. 

Phrase: "The blocking solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "replaced with blocking solution"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1554078:Replace [Idea or Concept]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the desired concentration of primary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.328: The western blot was visualized with the Amersham Chemiluminescent western blot detection kit.  

Phrase: "The western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "visualized with the Amersham Chemiluminescent western blot detection kit."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0949466:Western Blot [Laboratory Procedure]
   742   C0234621:Visualized [Functional Concept]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C1705493:Western [Spatial Concept]
   742   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.329: ACKNOWLEDGEMENTS  We thank Professor Alexis Brice of INSERM U289, Hpital de la Salpetrire, Paris, France for the missense mutated parkin cDNA constructs, and Ms Maria Dy for technical assistance. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Professor Alexis Brice of INSERM U289,"

Phrase: "Hpital de la Salpetrire,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France for the missense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016674:France [Geographic Area]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "parkin cDNA constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "Ms Maria Dy for technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2826182:DY [Temporal Concept]
Processing 00000000.tx.330: We also thank Dr Harry V. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Harry V."
Processing 00000000.tx.331: Vinters, director of the UCLA Alzheimer Disease Center Neuropathology/Tissue Core, for the frozen and paraffin-embedded human brain tissues. 

Phrase: "Vinters,"

Phrase: "director of the UCLA Alzheimer Disease Center Neuropathology/Tissue Core,"

Phrase: "for the frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "paraffin-embedded human brain tissues."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   900   C1519524:Paraffin Embedded Tissue [Tissue]
           Tissue, Paraffin
   853   C0440744:human tissues [Tissue]
   840   C0440746:brain tissues [Tissue]
   806 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0040300:Tissues [Tissue]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   771 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.332: This study was supported by the Carmen and Louis Warschaw endowment, F.R.I.E.N.D.s of Neurology, NIH grant RO1-NS33124 to S.M.P., and an NIH long-term disability supplement to H.P.D.  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by the Carmen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1367449:CARMEN [Gene or Genome]
   770   C1521721:Supported [Conceptual Entity]
   770   C1706590:CARMEN [Gene or Genome]
   737 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Louis Warschaw endowment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014265:Endowment [Quantitative Concept]

Phrase: "F.R.I.E.N.D.s"

Phrase: "of Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "NIH grant RO1-NS33124 to S."

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "an NIH long-term disability supplement to H.P.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0242295:Supplement [Food]
   739   C1947943:Supplement [Intellectual Product]
   739   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.333: FOOTNOTES  * To whom correspondence should be addressed at: 8700 Beverly Blvd, Davis Research Blvd, Room 2091, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "8700 Beverly Blvd,"

Phrase: "Davis"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Blvd,"

Phrase: "Room 2091,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Cedars-Sinai Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA 90048,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.334: Tel: +1 3104235166; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 3104235166"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.335: Fax: +1 8108212407; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 8108212407"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.336: Email: pulst{at}cshs.org  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Dunnett, S.B. and Bjorklund, A. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "pulst{at}cshs.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1522486:ORG [Professional or Occupational Group]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Dunnett,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bjorklund,"

Phrase: "A."
Processing 00000000.tx.337: (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Prospects for new restorative"

Phrase: "and"

Phrase: "neuroprotective treatments in Parkinson's disease."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   760   C0087111:Treatments [Therapeutic or Preventive Procedure]
   726 E C0039798:treatment [Functional Concept]
   726 E C1522326:Treatment [Functional Concept]
   726 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   726 E C1705169:Treatment [Conceptual Entity]
   726 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.338: Nature, 399, A3239.[CrossRef][ISI][Medline] Yamada, T., McGeer, P.L., Baimbridge, K.G. and McGeer, E.G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "399,"

Phrase: "A3239."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McGeer,"

Phrase: "P.L., Baimbridge,"

Phrase: "K.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "E.G."
Processing 00000000.tx.339: (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Relative sparing in Parkinson's disease of substantia nigra dopamine neurons"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "calbindin-D28K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.340: Brain Res., 526, 303307.[CrossRef][ISI][Medline] Damier, P., Hirsch, E.C., Agid, Y. and Graybiel, A.M. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "526,"

Phrase: "303307."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Damier,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hirsch,"

Phrase: "E.C.,"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Graybiel,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: (1999) The substantia nigra of the human brain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The substantia nigra of the human brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038590:BRAIN, SUBSTANTIA NIGRA [Body Part, Organ, or Organ Component]
           Substantia Nigra
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.342: II. 

Phrase: "II."
Processing 00000000.tx.343: Patterns of loss of dopamine-containing neurons in Parkinson's disease. 

Phrase: "Patterns of loss of dopamine-containing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.344: Brain, 122 (Pt 8), 14371448.[Abstract/Free FullText] Naoi, M. and Maruyama, W. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "122"

Phrase: "(Pt 8"

Phrase: ")"

Phrase: ","

Phrase: "14371448."

Phrase: "[Abstract/Free FullText"

Phrase: "] Naoi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Maruyama,"

Phrase: "W."
Processing 00000000.tx.345: (1999) Cell death of dopamine neurons in aging and Parkinson's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell death of dopamine neurons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C2754100:neuron cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.346: Mech. 

Phrase: "Mech."
Processing 00000000.tx.347: Ageing Dev., 111, 175188.[CrossRef][ISI][Medline] Le, W.D., Xu, P., Jankovic, J., Jiang, H., Appel, S.H., Smith, R.G. and Vassilatis, D.K. 

Phrase: "Ageing Dev.,"

Phrase: "111,"

Phrase: "175188."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "W."

Phrase: "D."

Phrase: ","

Phrase: "Xu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jankovic,"

Phrase: "J.,"

Phrase: "Jiang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Appel,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Vassilatis,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.348: (2003) Mutations in NR4A2 associated with familial Parkinson disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in NR4A2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with familial Parkinson disease."
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0243083:associated disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.349: Nat. 

Phrase: "Nat."
Processing 00000000.tx.350: Genet., 33, 8589.[CrossRef][ISI][Medline] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "33,"

Phrase: "8589."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.351: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.352: Science, 276, 20452047.[Abstract/Free FullText] Wintermeyer, P., Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Berg, D., Becker, G., Leroy, E., Polymeropoulos, M., Berger, K. et al. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wintermeyer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Berg,"

Phrase: "D."

Phrase: ","

Phrase: "Becker,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: ","

Phrase: "Berger,"

Phrase: "K. et al."
Processing 00000000.tx.353: (2000) Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mutation analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0796357:mutation analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies of the UCHL1 gene"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   784   C1421267:Ubiquitin C Gene [Gene or Genome]
           UBIQUITIN C
   764   C0949722:Ubiquitin C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1523983:Ubiquitin C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1707271:C-Terminal [Amino Acid Sequence]
   762   C1273305:Gene studies [Laboratory Procedure]
   742   C0017337:Gene [Gene or Genome]
   742   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C0441918:L1 [Finding]
   742   C0557651:Study [Manufactured Object]
   742   C0947630:studies [Laboratory Procedure]
   742   C1179698:L1 [Body Location or Region]
   742   C1416177:L1 [Gene or Genome]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C2603343:Study [Research Activity]

Phrase: "in German Parkinson's disease patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.354: Neuroreport, 11, 20792082.[ISI][Medline] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Neuroreport,"

Phrase: "11,"

Phrase: "20792082."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.355: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.356: Nature, 392, 605608.[CrossRef][ISI][Medline] Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "van Baren,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Schaap,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Breedveld,"

Phrase: "G.J.,"

Phrase: "Krieger,"

Phrase: "E.,"

Phrase: "Dekker,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Squitieri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Joosse,"

Phrase: "M. et al."
Processing 00000000.tx.357: (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in the DJ-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with autosomal recessive early-onset parkinsonism."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1838631:Parkinsonism, early-onset [Finding]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.358: Science, 299, 256259.[Abstract/Free FullText] Ishikawa, A. and Tsuji, S. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "299,"

Phrase: "256259."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ishikawa,"

Phrase: "A."

Phrase: "and"

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.359: (1996) Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clinical analysis of 17 patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in 12 Japanese families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "with autosomal-recessive type juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   924   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   911   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   840   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   804   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.360: Neurology, 47, 160166.[Abstract] Ishikawa, A. and Takahashi, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "160166."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ishikawa,"

Phrase: "A."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.361: (1998) Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological aspects of autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Neurol., 245, P49.[ISI][Medline] Matsumine, H. 

Phrase: "Neurol.,"

Phrase: "245,"

Phrase: "P49."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539847:p49 [Gene or Genome]

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matsumine,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.364: (1998) A loss-of-function mechanism of nigral neuron death without Lewy body formation: autosomal recessive juvenile parkinsonism (AR-JP). 

Phrase: "(1998"

Phrase: ")"

Phrase: "A loss-of-function mechanism of nigral neuron death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "without Lewy body formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: ":"

Phrase: "autosomal recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.365: J Neurol, 245, P1014.[ISI][Medline] Abbas, N., Lucking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. 

Phrase: "J Neurol,"

Phrase: "245,"

Phrase: "P1014."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Marconi,"

Phrase: "R. et al."
Processing 00000000.tx.366: (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A wide variety of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "responsible for autosomal recessive parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]
Processing 00000000.tx.367: French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "French Parkinson's Disease Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.368: Hum. 

Phrase: "Hum."
Processing 00000000.tx.369: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.370: Genet., 8, 567574.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "567574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. et al."
Processing 00000000.tx.371: (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial Parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin-protein ligase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1442769:ubiquitin-protein ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.372: Nat. 

Phrase: "Nat."
Processing 00000000.tx.373: Genet., 25, 302305.[CrossRef][ISI][Medline] Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshikawa,"

Phrase: "M."

Phrase: ","

Phrase: "Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Shimizu,"

Phrase: "N. et al."
Processing 00000000.tx.374: (1999) Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunohistochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441616:Immunohistochemical [Laboratory Procedure]

Phrase: "and"

Phrase: "subcellular localization of Parkin protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: ":"

Phrase: "absence of protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "in autosomal recessive juvenile parkinsonism patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0030705:Patients [Patient or Disabled Group]
   771   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   722   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.375: Ann. 

Phrase: "Ann."
Processing 00000000.tx.376: Neurol., 45, 668672.[CrossRef][ISI][Medline] Finney, N., Walther, F., Mantel, P.Y., Stauffer, D., Rovelli, G. and Dev, K.K. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "668672."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Finney,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Walther,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mantel,"

Phrase: "P.Y.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Stauffer,"

Phrase: "D."

Phrase: ","

Phrase: "Rovelli,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dev,"

Phrase: "K.K."
Processing 00000000.tx.377: (2003) The cellular protein level of Parkin is regulated by its ubiquitin-like domain. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The cellular protein level of Parkin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0428479:Protein level [Laboratory or Test Result]
   783   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "regulated by its ubiquitin-like domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.378: J. 

Phrase: "J."
Processing 00000000.tx.379: Biol. 

Phrase: "Biol."
Processing 00000000.tx.380: Chem., 278, 1605416058.[Abstract/Free FullText] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "1605416058."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.381: (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitin-protein ligase"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1442769:ubiquitin-protein ligase [Gene or Genome]
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031843:function [Physiologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1705273:Function [Intellectual Product]
   744   C3244310:dependent [Functional Concept]
   744   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.382: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.383: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.384: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.385: USA, 97, 1335413359.[Abstract/Free FullText] Joazeiro, C.A. and Weissman, A.M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Joazeiro,"

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Weissman,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: (2000) RING finger proteins: mediators of ubiquitin ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "RING finger proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1313794:RING Finger Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   734   C1521759:Ring Finger [Cell Component]

Phrase: ":"

Phrase: "mediators of ubiquitin ligase activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.387: Cell, 102, 549552.[ISI][Medline] Helliwell, S.B., Losko, S. and Kaiser, C.A. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "102,"

Phrase: "549552."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Helliwell,"

Phrase: "S."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Losko,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kaiser,"

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.388: (2001) Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Components of a ubiquitin ligase complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "specify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "polyubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514216:Polyubiquitination [Molecular Function]

Phrase: "and"

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "trafficking of the general amino acid permease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0051609:Amino Acid Permease [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0031165:permease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0205246:General [Spatial Concept]
   748   C0599896:trafficking [Cell Function]
   748   C1553889:General [Idea or Concept]
Processing 00000000.tx.389: J. 

Phrase: "J."
Processing 00000000.tx.390: Cell Biol., 153, 649662.[Abstract/Free FullText] Hicke, L. 

Phrase: "Cell Biol.,"

Phrase: "153,"

Phrase: "649662."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hicke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.391: (2001) A new ticket for entry into budding vesiclesubiquitin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A new ticket for entry"

Phrase: "into budding vesiclesubiquitin."
Processing 00000000.tx.392: Cell, 106, 527530.[ISI][Medline] Hicke, L. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "106,"

Phrase: "527530."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hicke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.393: (2001) Protein regulation by monoubiquitin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Protein regulation by monoubiquitin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.394: Nat. 

Phrase: "Nat."
Processing 00000000.tx.395: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.396: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.397: Cell Biol., 2, 195201.[CrossRef][ISI][Medline] Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "195201."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.399: Cell, 105, 891902.[CrossRef][ISI][Medline] Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.400: (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitination of a new form of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.401: Science, 293, 263269.[Abstract/Free FullText] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.402: (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the alpha-synuclein-interacting protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3541909:Alpha-Synuclein-Interacting Protein [Amino Acid, Peptide, or Protein]
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.403: Nat. 

Phrase: "Nat."
Processing 00000000.tx.404: Med., 7, 11441150.[CrossRef][ISI][Medline] Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Hatakeyama,"

Phrase: "S."

Phrase: ","

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakayama,"

Phrase: "K.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. 

Phrase: "(2002"

Phrase: ")"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "is"

Phrase: "associated with Parkin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "responsible for familial Parkinson's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its ubiquitin ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150685:ubiquitin-ligase activity [Molecular Function]
   913   C1325411:ubiquitin activity [Molecular Function]
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.406: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.407: Cell., 10, 5567.[ISI][Medline] Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. 

Phrase: "Cell.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "10,"

Phrase: "5567."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Staropoli,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McDermott,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martinat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schulman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Demireva,"

Phrase: "E."

Phrase: "and"

Phrase: "Abeliovich,"

Phrase: "A."
Processing 00000000.tx.408: (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a component of an SCF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "like ubiquitin ligase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167313:ubiquitin ligase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "protects"

Phrase: "postmitotic neurons from kainate excitotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.409: Neuron, 37, 735749.[ISI][Medline] Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "735749."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tsai,"

Phrase: "Y.C., Fishman,"

Phrase: "P.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "Thakor,"

Phrase: "N.V."

Phrase: "and"

Phrase: "Oyler,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.410: (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitates"

Phrase: "the elimination of expanded polyglutamine proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "leads to preservation of proteasome function."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   783   C3640044:Lead Function [Conceptual Entity]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0031843:function [Physiologic Function]
   753   C0033085:Preservation [Laboratory Procedure]
   753   C0181586:leads [Medical Device]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1325620:proteasome [Cell Component]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1514402:Preservation [Laboratory Procedure]
   753   C1522538:Lead [Functional Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1752727:Proteasome [Molecular Function]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.411: J. 

Phrase: "J."
Processing 00000000.tx.412: Biol. 

Phrase: "Biol."
Processing 00000000.tx.413: Chem., 278, 2204422055.[Abstract/Free FullText] Ren, Y., Zhao, J. and Feng, J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "2204422055."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "Y.,"

Phrase: "Zhao,"

Phrase: "J."

Phrase: "and"

Phrase: "Feng,"

Phrase: "J."
Processing 00000000.tx.414: (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "binds to alpha/beta tubulin"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0005290:beta-Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1421231:TUBULIN, BETA [Gene or Genome]
   806   C3539817:Tubulin, Beta [Amino Acid, Peptide, or Protein]
   797   C0002318:alpha-Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0330390:Beta [Plant]
   760   C0439095:Alpha [Intellectual Product]
   760   C0439096:Beta [Intellectual Product]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C2003941:Alpha [Intellectual Product]
   760   C2004068:Beta [Qualitative Concept]
   760   C2350010:Alpha [Qualitative Concept]
   760   C2937342:tubulin [Cell Component]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.415: J. 

Phrase: "J."
Processing 00000000.tx.416: Neurosci., 23, 33163324.[Abstract/Free FullText] Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. 

Phrase: "Neurosci.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "33163324."

Phrase: "[Abstract/Free FullText"

Phrase: "] Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hampe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koutnikova,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Darios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jacquier,"

Phrase: "S."

Phrase: ","

Phrase: "Prigent,"

Phrase: "A.,"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Mirande,"

Phrase: "M. et al."
Processing 00000000.tx.417: (2003) The p38 subunit of the aminoacyltRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The p38 subunit of the aminoacyltRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "protein biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597295:Protein Biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.418: Hum. 

Phrase: "Hum."
Processing 00000000.tx.419: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.420: Genet., 12, 14271437.[Abstract/Free FullText] Fields, S. and Song, O. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "14271437."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.421: (1989) A novel genetic system to detect proteinprotein interactions. 

Phrase: "(1989"

Phrase: ")"

Phrase: "A novel genetic system to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0559522:Genital system [Body System]
   819   C1283795:Genital system [Body System]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "proteinprotein interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.422: Nature, 340, 245246.[CrossRef][ISI][Medline] Scoles, D.R., Huynh, D.P., Chen, M.S., Burke, S.P., Gutmann, D.H. and Pulst, S.M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "340,"

Phrase: "245246."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Burke"

Phrase: ","

Phrase: "S.P.,"

Phrase: "Gutmann,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.423: (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The neurofibromatosis 2 tumor suppressor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0597611:Tumor suppressor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0260034:tumor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with hepatocyte growth factor-regulated tyrosine kinase substrate."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   919   C0382631:hepatocyte growth factor-regulated tyrosine kinase substrate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   919   C1366514:HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE [Gene or Genome]
   790   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0227525:Hepatocyte [Cell]
   742   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1710236:Substrate [Manufactured Object]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
Processing 00000000.tx.424: Hum. 

Phrase: "Hum."
Processing 00000000.tx.425: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.426: Genet., 9, 15671574.[Abstract/Free FullText] Engelender, S., Kaminsky, Z., Guo, X., Sharp, A.H., Amaravi, R.K., Kleiderlein, J.J., Margolis, R.L., Troncoso, J.C., Lanahan, A.A., Worley, P.F. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "15671574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Kaminsky,"

Phrase: "Z.,"

Phrase: "Guo,"

Phrase: "X.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Amaravi,"

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kleiderlein,"

Phrase: "J.J.,"

Phrase: "Margolis,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Troncoso,"

Phrase: "J.C., Lanahan,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Worley,"

Phrase: "P.F. et al."
Processing 00000000.tx.427: (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "associates with alpha-synuclein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439095:Alpha [Intellectual Product]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of cytosolic inclusions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.428: Nat. 

Phrase: "Nat."
Processing 00000000.tx.429: Genet., 22, 110114.[CrossRef][ISI][Medline] Huynh, D.P., Scoles, D.R., Ho, T.H., Del Bigio, M.R. and Pulst, S.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "110114."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "T.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Del Bigio,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.430: (2000) Parkin is associated with actin filaments in neuronal and nonneural cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "associated with actin filaments"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0025979:Actin Filaments [Cell Component]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   791 E C1622186:Actin.filamentous [Cell Component]
   777 E C1180307:Filamentous Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0010851:Filament [Cell Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "nonneural cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.431: Ann. 

Phrase: "Ann."
Processing 00000000.tx.432: Neurol., 48, 737744.[CrossRef][ISI][Medline] Ribeiro, C.S., Carneiro, K., Ross, C.A., Menezes, J.R. and Engelender, S. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "737744."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ribeiro,"

Phrase: "C.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Carneiro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Menezes,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Engelender,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: (2002) Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "developmentally"

Phrase: "localized to synaptic terminals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0206181:Synaptic Terminals [Cell Component]
   770   C0392752:Localized [Spatial Concept]
   737   C0205088:Terminal [Temporal Concept]
   737   C1705314:Terminal [Manufactured Object]
   737   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "its association with synaptic vesicles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "modulated by alpha-synuclein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439095:Alpha [Intellectual Product]
   770   C0443264:Modulated [Spatial Concept]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.434: J. 

Phrase: "J."
Processing 00000000.tx.435: Biol. 

Phrase: "Biol."
Processing 00000000.tx.436: Chem., 277, 2392723933.[Abstract/Free FullText] Wakabayashi, K., Engelender, S., Tanaka, Y., Yoshimoto, M., Mori, F., Tsuji, S., Ross, C.A. and Takahashi, H. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "2392723933."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.437: (2002) Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Immunocytochemical localization of synphilin-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "an alpha-synuclein-associated protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.438: Acta Neuropathol. 

Phrase: "Acta Neuropathol."
Processing 00000000.tx.439: (Berl.), 103, 209214.[CrossRef][ISI][Medline] Beites, C.L., Xie, H., Bowser, R. and Trimble, W.S. 

Phrase: "(Berl."

Phrase: ")"

Phrase: ","

Phrase: "103,"

Phrase: "209214."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beites,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Xie,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowser,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Trimble,"

Phrase: "W.S."
Processing 00000000.tx.440: (1999) The septin CDCrel-1 binds syntaxin and inhibits exocytosis. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The septin CDCrel-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1414049:SEPTIN 1 [Gene or Genome]
   901   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   901   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   827   C1539748:CDCREL [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.441: Nat. 

Phrase: "Nat."
Processing 00000000.tx.442: Neurosci., 2, 434439.[CrossRef][ISI][Medline] Scoles, D.R., Nguyen, V.D., Qin, Y., Sun, C.X., Morrison, H., Gutmann, D.H. and Pulst, S.M. 

Phrase: "Neurosci.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "434439."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "V.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231965:V D [Laboratory or Test Result]

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "Y.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "C.X.,"

Phrase: "Morrison,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gutmann,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.443: (2002) Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurofibromatosis 2 (NF2) tumor suppressor schwannomin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0085114:SCHWANNOMIN [Gene or Genome]
   804   C0254123:Schwannomin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its interacting protein HRS"

Phrase: "regulate"

Phrase: "STAT signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.444: Hum. 

Phrase: "Hum."
Processing 00000000.tx.445: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.446: Genet., 11, 31793189.[Abstract/Free FullText] Fernandez-Chacon, R., Konigstorfer, A., Gerber, S.H., Garcia, J., Matos, M.F., Stevens, C.F., Brose, N., Rizo, J., Rosenmund, C. and Sudhof, T.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "31793189."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fernandez-Chacon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Konigstorfer,"

Phrase: "A.,"

Phrase: "Gerber,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "J.,"

Phrase: "Matos,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brose,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rizo,"

Phrase: "J.,"

Phrase: "Rosenmund,"

Phrase: "C."

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.447: (2001) Synaptotagmin I functions as a calcium regulator of release probability. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Synaptotagmin I functions as a calcium regulator of release probability."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0542341:Functions [Functional Concept]
   706 E C0031843:function [Physiologic Function]
   706 E C0700205:FUNCTION [Classification]
   706 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.448: Nature, 410, 4149.[CrossRef][ISI][Medline] Geppert, M., Goda, Y., Hammer, R.E., Li, C., Rosahl, T.W., Stevens, C.F. and Sudhof, T.C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "410,"

Phrase: "4149."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Geppert,"

Phrase: "M."

Phrase: ","

Phrase: "Goda,"

Phrase: "Y.,"

Phrase: "Hammer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181107:Hammer [Manufactured Object]

Phrase: "R.E.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rosahl,"

Phrase: "T.W., Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551756:Stevens [Population Group]

Phrase: "C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.449: (1994) Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Synaptotagmin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0144255:synaptotagmin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420556:synaptotagmin I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "a major Ca2+ sensor for transmitter release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0183210:Sensor [Medical Device]
   748   C1705193:Sensor [Manufactured Object]

Phrase: "at a central synapse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039062:Synapse [Body Space or Junction]
Processing 00000000.tx.450: Cell, 79, 717727.[ISI][Medline] von Poser, C., Ichtchenko, K., Shao, X., Rizo, J. and Sudhof, T.C. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "79,"

Phrase: "717727."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] von Poser,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ichtchenko,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shao,"

Phrase: "X.,"

Phrase: "Rizo,"

Phrase: "J."

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.451: (1997) The evolutionary pressure to inactivate. 

Phrase: "(1997"

Phrase: ")"

Phrase: "The evolutionary pressure to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]

Phrase: "inactivate."
Processing 00000000.tx.452: A subclass of synaptotagmins with an amino acid substitution that abolishes Ca2+ binding. 

Phrase: "A subclass of synaptotagmins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445604:Subclass [Classification]

Phrase: "with an amino acid substitution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "that"

Phrase: "abolishes"

Phrase: "Ca2+ binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.453: J. 

Phrase: "J."
Processing 00000000.tx.454: Biol. 

Phrase: "Biol."
Processing 00000000.tx.455: Chem., 272, 1431414319.[Abstract/Free FullText] Wang, C.T., Grishanin, R., Earles, C.A., Chang, P.Y., Martin, T.F., Chapman, E.R. and Jackson, M.B. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "1431414319."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "C.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Grishanin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Earles,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Chang,"

Phrase: "P.Y.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "T.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Chapman,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Jackson,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: (2001) Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Synaptotagmin modulation of fusion pore kinetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "in regulated exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "of dense-core vesicles."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887944:Dense Core Vesicles [Cell Component]
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.457: Science, 294, 11111115.[Abstract/Free FullText] Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C.A. and Takahashi, H. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "294,"

Phrase: "11111115."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.458: (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "present in Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.459: Ann. 

Phrase: "Ann."
Processing 00000000.tx.460: Neurol., 47, 521523.[CrossRef][ISI][Medline] Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. 

Phrase: "Neurol.,"

Phrase: "47,"

Phrase: "521523."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W.P.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Sharma,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ochiishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sharon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hattori,"

Phrase: "N. et al."
Processing 00000000.tx.461: (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "localizes to the Lewy bodies of Parkinson disease"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   812   C0030567:bodies disease lewy parkinson's [Disease or Syndrome]
           Parkinson Disease
   789   C0752347:bodies disease lewy [Disease or Syndrome]
   770   C0085200:Lewy Bodies [Cell Component]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0242821:bodies [Human]
   744   C0392752:localize [Spatial Concept]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.462: Am. 

Phrase: "Am."
Processing 00000000.tx.463: J. 

Phrase: "J."
Processing 00000000.tx.464: Pathol., 160, 16551667.[Abstract/Free FullText] Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. 

Phrase: "Pathol.,"

Phrase: "160,"

Phrase: "16551667."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Nagai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ozawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.465: (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "An autopsy case of autosomal-recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004398:Autopsy [Diagnostic Procedure]
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]

Phrase: "with a homozygous exon 4 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in the parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.466: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.467: Disord., 15, 884888.[CrossRef][ISI][Medline] Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. 

Phrase: "Disord.,"

Phrase: "15,"

Phrase: "884888."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa-Hattori,"

Phrase: "Y.,"

Phrase: "Miyake,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.468: (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathologic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1521733:Pathologic [Functional Concept]
   928 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "biochemical studies of juvenile parkinsonism"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C2699049:JUVENILE STUDIES [Regulation or Law]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "linked to chromosome 6q."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C1521554:6q [Nucleotide Sequence]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.469: Neurology, 51, 890892.[Abstract] van de Warrenburg, B.P., Lammens, M., Lucking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "890892."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] van de Warrenburg,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Lammens,"

Phrase: "M."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wesseling,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Booij,"

Phrase: "J.,"

Phrase: "Praamstra,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.470: (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologic abnormalities in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "parkin gene mutations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0596611:gene mutations [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.471: Neurology, 56, 555557.[Abstract/Free FullText] Imai, Y., Soda, M. and Takahashi, R. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "555557."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.472: (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitinprotein ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "unfolded protein stress-induced cell death through its E3 ubiquitinprotein ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007587:Cell Death [Cell Function]
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.473: J. 

Phrase: "J."
Processing 00000000.tx.474: Biol. 

Phrase: "Biol."
Processing 00000000.tx.475: Chem., 275, 3566135664.[Abstract/Free FullText] Fukuda, M. and Mikoshiba, K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3566135664."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukuda,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mikoshiba,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: (2001) Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII). 

Phrase: "(2001"

Phrase: ")"

Phrase: "Characterization of KIAA1427 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "as an atypical synaptotagmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syt XIII"

Phrase: ")."
Processing 00000000.tx.477: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.478: J., 354, 249257.[CrossRef][ISI][Medline] Berton, F., Cornet, V., Iborra, C., Garrido, J., Dargent, B., Fukuda, M., Seagar, M. and Marqueze, B. 

Phrase: "J.,"

Phrase: "354,"

Phrase: "249257."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Berton,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cornet,"

Phrase: "V.,"

Phrase: "Iborra,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Garrido,"

Phrase: "J.,"

Phrase: "Dargent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fukuda,"

Phrase: "M."

Phrase: ","

Phrase: "Seagar,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Marqueze,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.479: (2000) Synaptotagmin I and IV define distinct populations of neuronal transport vesicles. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Synaptotagmin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0144255:synaptotagmin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420556:synaptotagmin I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV"

Phrase: "define"

Phrase: "distinct populations of neuronal transport vesicles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]
Processing 00000000.tx.480: Eur. 

Phrase: "Eur."
Processing 00000000.tx.481: J. 

Phrase: "J."
Processing 00000000.tx.482: Neurosci., 12, 12941302.[CrossRef][ISI][Medline] Ibata, K., Fukuda, M., Hamada, T., Kabayama, H. and Mikoshiba, K. 

Phrase: "Neurosci.,"

Phrase: "12,"

Phrase: "12941302."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ibata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukuda,"

Phrase: "M."

Phrase: ","

Phrase: "Hamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kabayama,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mikoshiba,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.483: (2000) Synaptotagmin IV is present at the Golgi and distal parts of neurites. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Synaptotagmin IV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0286878:synaptotagmin IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420559:synaptotagmin IV [Gene or Genome]
   861   C0084697:Synaptotagmin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present at the Golgi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "distal parts of neurites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1292711:Part of [Spatial Concept]
   770   C0449719:parts [Spatial Concept]
   770   C1709471:PARTS [Quantitative Concept]
Processing 00000000.tx.484: J. 

Phrase: "J."
Processing 00000000.tx.485: Neurochem., 74, 518526.[CrossRef][ISI][Medline] Fukuda, M., Ibata, K. and Mikoshiba, K. 

Phrase: "Neurochem.,"

Phrase: "74,"

Phrase: "518526."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fukuda,"

Phrase: "M."

Phrase: ","

Phrase: "Ibata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mikoshiba,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.486: (2001) A unique spacer domain of synaptotagmin IV is essential for Golgi localization. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A unique spacer domain of synaptotagmin IV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "essential for Golgi localization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.487: J. 

Phrase: "J."
Processing 00000000.tx.488: Neurochem., 77, 730740.[CrossRef][ISI][Medline] Fukuda, M., Kanno, E., Ogata, Y., Saegusa, C., Kim, T., Loh, Y.P. and Yamamoto, A. 

Phrase: "Neurochem.,"

Phrase: "77,"

Phrase: "730740."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fukuda,"

Phrase: "M."

Phrase: ","

Phrase: "Kanno,"

Phrase: "E.,"

Phrase: "Ogata,"

Phrase: "Y.,"

Phrase: "Saegusa,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kim,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Loh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524869:LOH [Genetic Function]

Phrase: "Y.P."

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A."
Processing 00000000.tx.489: (2003) Nerve growth factor-dependent sorting of synaptotagmin IV protein to mature dense-core vesicles that undergo calcium-dependent exocytosis in PC12 cells. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nerve growth factor-dependent sorting of synaptotagmin IV protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0887837:Protein Sorting [Cell Function]
   742   C0237886:Sorting [Mental Process]
   742   C0700314:sorting [Cell Function]
   742   C1947906:Sorting [Activity]

Phrase: "to mature dense-core vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   923   C0887944:Dense Core Vesicles [Cell Component]
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "that"

Phrase: "undergo"

Phrase: "calcium-dependent exocytosis in PC12 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.490: J. 

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem., 278, 32203226.[Abstract/Free FullText] Shibata, H., Huynh, D.P. and Pulst, S.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "32203226."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shibata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huynh,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A novel protein with RNA-binding motifs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   804   C0085177:RNA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1421986:RNA-binding protein [Gene or Genome]
   804   C1826636:RNA binding protein [Gene or Genome]
   793   C1514535:Protein Binding Motif [Amino Acid Sequence]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0752190:Protein Motifs [Spatial Concept]
   757 E C1514562:Protein Motif [Amino Acid Sequence]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with ataxin-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0531288:ataxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1538299:ATAXIN 2 [Gene or Genome]
Processing 00000000.tx.494: Hum. 

Phrase: "Hum."
Processing 00000000.tx.495: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.496: Genet., 9, 13031313.[Abstract/Free FullText] Scoles, D.R., Huynh, D.P., Morcos, P.A., Coulsell, E.R., Robinson, N.G., Tamanoi, F. and Pulst, S.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "13031313."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Morcos,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Coulsell,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tamanoi,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.497: (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurofibromatosis 2 tumour suppressor schwannomin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0085114:SCHWANNOMIN [Gene or Genome]
   804   C0254123:Schwannomin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with betaII-spectrin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1420388:SPECTRIN, BETA-II [Gene or Genome]
   770   C0037799:Spectrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1166668:spectrin [Cell Component]
Processing 00000000.tx.498: Nat. 

Phrase: "Nat."
Processing 00000000.tx.499: Genet., 18, 354359.[ISI][Medline] Poullet, P. and Tamanoi, F. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "354359."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Poullet,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tamanoi,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.500: (1995) Use of yeast two-hybrid system to evaluate Ras interactions with neurofibromin-GTPase-activating protein. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Use of yeast two-hybrid system to"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   853   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
   853   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   778   C1524063:Use of [Functional Concept]
   748   C0020205:Hybrid [Organism]
   748   C0036025:yeast [Fungus]
   748   C0042153:use [Functional Concept]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0205448:Two [Quantitative Concept]
   748   C0449913:System [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1947944:Use [Intellectual Product]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "Ras interactions with neurofibromin-GTPase-activating protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0872079:interactions protein [Molecular Function]
   714   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.501: Methods Enzymol., 255, 488497.[ISI][Medline]

Phrase: "Methods Enzymol.,"

Phrase: "255,"

Phrase: "488497."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

